Respiratory diseases principally affecting the interstitium, IBD co-morbidites

IBD_PULM

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints J10_PULMEOS J10_OTHERINSTPULM	6889
6. Filter based on genotype QC (FinnGen only)	6699

Control definitions (FinnGen only)

Control exclude: IBD_COMORB

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	IBD_PULM
CONTROL_EXCLUDE	IBD_COMORB
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	J10_PULMEOS\|J10_OTHERINSTPULM
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Respiratory diseases principally affecting the interstitium, IBD co-morbidites based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6699	2714	3985
Unadjusted period prevalence (%)	1.48	0.96	1.83
Median age at first event (years)	69.42	66.62	71.33

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5677: Matched controls
40187

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.3

320.5

1079

2094

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

98.4

319.6

227

A10BK01

ATC

dapagliflozin; oral

34.1

319.3

267

S06.0

ICD-10 Finland

Concussion

13.2

312.6

372

212

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

+∞

312.5

340

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.7

308.2

1297

2963

B01AC04

ATC

clopidogrel; oral

4.6

308.0

934

1662

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

39.7

307.7

397

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

128.5

307.7

260

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

6.9

307.7

897

1058

R06.0

ICD-10 Finland

Dyspnoea

7.7

307.7

2394

3469

GD1AA

NOMESCO Finland

Thorax X-ray examination

8.7

307.7

3902

8088

L88

ICPC

Rheumatoid/seropositive arthritis

74.8

307.7

310

A07EC01

ATC

sulfasalazine; oral, rectal

23.5

307.7

598

200

J01MA12

ATC

levofloxacin; systemic

4.0

307.7

1425

3106

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

123.6

307.7

538

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

279.6

307.7

471

I50.9

ICD-10 Finland

Heart failure, unspecified

5.6

307.7

1118

1700

Z01.8

ICD-10 Finland

Other specified special examinations

4.4

307.7

1386

2776

T90

ICPC

Diabetes non-insulin dependent

22.3

307.7

1179

467

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

24.6

307.7

617

198

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

22.9

307.7

549

187

J96.1

ICD-10 Finland

Chronic respiratory failure

14.6

307.7

457

240

H02AB06

ATC

prednisolone; systemic

11.3

307.7

4289

8605

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

15178.7

307.7

1567

R03AC02

ATC

salbutamol; inhalant

4.5

307.7

3583

10996

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

41.1

307.7

425

L01BA01

ATC

methotrexate; systemic

75.6

307.7

332

J45.9

ICD-10 Finland

Asthma, unspecified

4.9

307.7

1307

2313

M25.5

ICD-10 Finland

Pain in joint

4.1

307.7

1334

2818

G47.3

ICD-10 Finland

Sleep apnoea

25.7

307.7

1211

419

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

53.1

307.7

2004

409

A10BB12

ATC

glimepiride; oral

101.1

307.7

259

XG410

NOMESCO Finland

Flow-volume spirometry

21.8

307.7

787

295

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

63.5

307.7

306

G56.0

ICD-10 Finland

Carpal tunnel syndrome

18.9

307.7

493

201

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.1

307.7

1625

3593

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.9

307.7

2298

5940

103

Kela drug reimbursment

Diabetes, insulin-treated

218.2

307.7

1325

GD1AD

NOMESCO Finland

Thorax CT examination

13.9

307.7

1098

682

A10AE04

ATC

insulin glargine; parenteral

92.7

307.7

402

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

10.2

307.7

702

548

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

3.7

307.7

1564

3714

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

4.1

307.7

1874

4281

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

11.3

307.7

485

329

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

15.5

307.7

557

280

SPAT1262

SPAT

Handing over of treatment supplies

8.8

307.7

974

926

215

Kela drug reimbursment

Diabetes, non-insulin-treated

398.4

307.7

1164

R02

ICPC

Shortness of breath/dyspnoea

5.6

307.7

946

1381

N02AX02

ATC

tramadol; systemic, rectal

4.6

307.7

2494

5842

M48.0

ICD-10 Finland

Spinal stenosis

53.1

307.7

628

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

8.9

307.7

774

700

N02AJ06

ATC

codeine and paracetamol; systemic

3.8

307.7

2032

5132

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

45.3

307.7

309

TGC00

NOMESCO Finland

Bronchial lavation

63.8

307.7

1310

188

A10AB05

ATC

insulin aspart; parenteral

72.6

307.7

392

356

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

307.7

489

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

9964.9

307.7

2462

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

8.7

307.7

879

833

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

46.4

307.7

930

169

R4110

NOMESCO Finland

Physiotherapy

3.5

307.7

1728

4438

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

12.4

307.7

551

346

J01MA14

ATC

moxifloxacin; systemic

6.3

307.7

905

1171

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

46.5

307.7

1247

242

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

5.3

307.7

2674

5807

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

3.8

307.7

1359

3038

C03CA01

ATC

furosemide; systemic

5.6

307.7

2361

4520

M54.5

ICD-10 Finland

Low back pain

3.7

307.7

1487

3492

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

56.5

307.7

252

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

119.1

307.7

506

TPH04

NOMESCO Finland

Cathetrisation of vein

3.9

307.7

1461

3307

R5140

NOMESCO Finland

Monitoring the use of the aid

15.3

307.7

665

346

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

7.2

307.7

701

775

J18.9

ICD-10 Finland

Pneumonia, unspecified

9.0

307.7

2942

4297

L04AA06

ATC

mycophenolic acid; systemic

50.9

307.7

463

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

49.7

307.7

356

UGC12

NOMESCO Finland

Flexible bronchoscopy

16.9

307.7

1961

1216

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

10.6

307.7

787

601

AA1AD

NOMESCO Finland

CT of head and brain

6.0

307.7

1381

2057

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

17.7

307.7

496

216

A10BK03

ATC

empagliflozin; oral

57.8

307.7

360

Z3226

NOMESCO Finland

Physiotherapist

4.6

307.7

1092

1985

E11

ICD-10 Finland

Type 2 diabetes mellitus

20.4

307.7

664

259

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

15.1

307.7

873

479

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

19.5

307.7

596

240

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

6.5

307.7

1014

1299

N02BE01

ATC

paracetamol; systemic, rectal

3.8

307.7

4714

22572

R03BB04

ATC

tiotropium bromide; inhalant

5.6

307.7

1051

1561

A10BA02

ATC

metformin; oral

53.6

307.7

1334

229

M13.9

ICD-10 Finland

Arthritis, unspecified

16.3

307.7

397

184

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

53.8

307.7

268

A10AC01

ATC

insulin (human); parenteral

59.1

307.7

418

M17.1

ICD-10 Finland

Other primary gonarthrosis

13.5

307.7

897

551

L04AX01

ATC

azathioprine; systemic

18.4

307.7

647

279

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

12.3

307.7

2077

1806

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

891.3

307.7

463

A10BH01

ATC

sitagliptin; oral

3147.3

307.7

420

P01BA02

ATC

hydroxychloroquine; oral

59.2

307.7

800

111

N03AX16

ATC

[U] pregabalin

6.9

307.7

1197

1490

L04AX03

ATC

methotrexate; systemic

21.6

307.7

713

265

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

8.0

307.7

576

560

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

257.8

307.7

617

M19.0

ICD-10 Finland

Primary arthrosis of other joints

14.2

307.7

388

207

M16.1

ICD-10 Finland

Other primary coxarthrosis

24.4

307.7

466

147

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

4.9

307.7

1306

2325

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4503599627370496.0

307.7

2854

A02BC02

ATC

pantoprazole; systemic

5.0

307.7

4207

14641

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

175.3

307.7

260

L28

ICPC

Limited function/disability (L)

5.5

307.7

873

1286

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

6.2

307.7

1131

1542

N03AX12

ATC

[U] gabapentin; oral

11.8

307.7

771

528

M79.6

ICD-10 Finland

Pain in limb

3.8

307.7

1849

4506

284

Kela drug reimbursment

Nintedanib and pirfenidone

+∞

307.7

500

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

60.7

307.7

1306

197

C07AB07

ATC

bisoprolol; oral

3.2

307.7

2913

9979

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1150.7

307.7

579

M04AA01

ATC

allopurinol; systemic

5.3

307.7

865

1321

R05

ICD-10 Finland

Cough

3.7

307.7

1398

3263

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

5.1

307.7

1425

2467

M05BA04

ATC

alendronic acid; oral

7.8

307.7

808

841

A28

ICPC

Limited function/disability NOS

4.5

301.5

926

1664

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

4.2

299.0

1031

2031

J45.1

ICD-10 Finland

Nonallergic asthma

6.7

298.1

583

679

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

3.6

295.3

1296

3040

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.3

291.4

1532

4041

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.3

288.8

1504

3941

XG466

NOMESCO Finland

Sleep oxymetry

19.9

288.1

284

106

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

12.4

287.9

354

214

A02BC01

ATC

omeprazole; systemic

3.2

286.8

1594

4347

C10AA01

ATC

simvastatin; oral

2.8

286.4

2344

7974

L04AX05

ATC

pirfenidone; oral

+∞

285.5

311

NF1AA

NOMESCO Finland

Hip X-ray examination

10.0

283.0

397

299

A02BC05

ATC

esomeprazole; systemic

2.9

279.8

2185

7227

R50.9

ICD-10 Finland

Fever, unspecified

4.0

278.3

1012

2069

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

5.0

276.8

736

1164

R03AK08

ATC

formoterol and beclometasone; inhalant

8.9

270.5

413

352

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

21.0

267.1

258

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

19.1

266.0

266

103

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.7

264.4

2830

10944

A10AE05

ATC

insulin detemir; parenteral

104.7

263.1

186

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

5.4

262.8

638

926

J01AA02

ATC

doxycycline; systemic

3.0

260.7

4372

21169

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

3.1

259.5

1513

4215

WX320

NOMESCO Finland

Spinalanesthesy

3.6

259.4

1128

2610

M10.9

ICD-10 Finland

Gout, unspecified

8.9

258.8

393

332

J01FA06

ATC

roxithromycin; oral

2.7

258.4

2273

7936

ZXA00

NOMESCO Finland

Right side

3.2

257.7

1392

3702

M54.4

ICD-10 Finland

Lumbago with sciatica

5.2

255.4

643

965

R03BA08

ATC

ciclesonide; inhalant

5.2

255.4

635

942

SPAT1263

SPAT

Sampling

2.7

251.8

2049

6852

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.8

250.8

985

2120

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

11.2

250.0

325

216

C10AA05

ATC

atorvastatin; oral

2.7

249.3

2220

7769

WX722

NOMESCO Finland

PEEP

13.5

249.0

292

161

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.2

249.0

1326

3488

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

7.7

248.6

424

418

B01AA03

ATC

warfarin; systemic

3.4

248.0

1203

2984

WX892

NOMESCO Finland

Monitored bed care

5.2

247.9

620

924

Z3231

NOMESCO Finland

Registered nurse

2.9

242.5

1576

4651

M01AX05

ATC

glucosamine; oral

4.1

241.2

840

1652

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

122.5

240.6

168

B01AB05

ATC

enoxaparin; parenteral

2.9

239.9

1598

4778

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

496.8

237.5

268

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

11.3

236.2

306

202

A49.9

ICD-10 Finland

Bacterial infection, unspecified

4.2

235.7

767

1430

C01DA14

ATC

isosorbide mononitrate; oral

3.6

235.4

998

2259

J01DB01

ATC

cefalexin; oral

2.8

233.3

4284

21069

H02AB07

ATC

prednisone; oral

3.7

232.5

920

1984

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

93.1

232.3

166

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

18.4

231.8

235

L01EX09

ATC

nintedanib; oral

+∞

231.7

253

S18

ICPC

Laceration/cut

2.6

230.8

2258

8211

A02BC03

ATC

lansoprazole; oral

2.9

230.7

1556

4671

L03

ICPC

Low back symptom/complaint

3.3

229.3

1150

2901

L04AA13

ATC

[U] leflunomide

383.0

227.5

259

ZXE00

NOMESCO Finland

One hour or less

2.6

226.8

2138

7621

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.8

226.0

846

1751

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.6

225.7

2000

6912

I50.0

ICD-10 Finland

Congestive heart failure

5.3

223.0

548

801

I10

ICD-10 Finland

Essential (primary) hypertension

2.5

222.8

3129

13413

ZXE10

NOMESCO Finland

More than one and less than three hours

2.6

218.6

1904

6504

N02BF01

ATC

gabapentin; oral

9.4

218.5

317

250

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

28.2

215.5

189

J01FF01

ATC

clindamycin; systemic

2.9

215.4

1433

4249

ACC51

NOMESCO Finland

Release of median nerve

361.3

214.7

245

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.9

214.7

1421

4201

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

15.6

214.0

233

110

J45.0

ICD-10 Finland

Predominantly allergic asthma

5.1

213.7

544

821

N06AA09

ATC

amitriptyline; systemic

6.1

212.6

442

546

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

19.5

212.0

210

R05

ICPC

Cough

3.0

211.9

1291

3641

R07.4

ICD-10 Finland

Chest pain, unspecified

2.8

209.1

1401

4163

L04AD01

ATC

ciclosporin; systemic

18.3

207.0

210

L17

ICPC

Foot/toe symptom/complaint

2.9

205.1

1281

3657

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

+∞

204.9

224

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

33.7

204.2

171

NE1AA

NOMESCO Finland

Pelvis X-ray examination

8.3

203.5

323

289

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

286.4

203.1

234

N02AA05

ATC

oxycodone; systemic

3.2

203.1

1020

2560

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.9

201.9

1292

3735

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

8.8

201.8

307

259

XF400

NOMESCO Finland

ECG with 12 standard connections

3.3

201.5

965

2350

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

58.2

201.2

152

ZXA05

NOMESCO Finland

Left side

2.9

200.1

1274

3671

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

4.2

198.2

647

1203

127

Kela drug reimbursment

Transplant complication

20.5

196.7

191

J01MA02

ATC

ciprofloxacin; systemic

2.4

196.1

2121

7950

UJF32

NOMESCO Finland

Coloscopy

2.7

194.9

1406

4326

R04.2

ICD-10 Finland

Haemoptysis

7.1

194.4

350

367

M20.1

ICD-10 Finland

Hallux valgus (acquired)

9.4

194.4

282

222

M01AH01

ATC

celecoxib; oral

3.7

193.8

770

1654

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.9

193.0

1168

3265

J01CA04

ATC

amoxicillin; systemic

2.5

192.7

4262

21792

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.3

192.6

899

2150

J47

ICD-10 Finland

Bronchiectasis

11.7

192.5

243

153

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

531.5

192.4

217

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

18.8

192.3

193

M01AH05

ATC

etoricoxib; oral

2.3

191.6

2701

11347

M01AH02

ATC

rofecoxib; oral

4.2

189.1

610

1122

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

6.5

188.9

369

425

R4120

NOMESCO Finland

Occupational therapy

8.7

188.6

289

246

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

516.2

186.9

211

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

5.0

185.8

477

723

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

21.3

185.8

178

G44.2

ICD-10 Finland

Tension-type headache

5.0

184.7

478

730

N06AX11

ATC

mirtazapine; oral

2.6

184.6

1524

5004

R53

ICD-10 Finland

Malaise and fatigue

3.0

182.3

1024

2735

C09AA05

ATC

ramipril; oral

2.6

182.3

1401

4435

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.4

182.2

1776

6307

C08CA01

ATC

amlodipine; oral

2.4

182.0

1936

7153

A10BH05

ATC

linagliptin; oral

744.4

181.4

203

R60.0

ICD-10 Finland

Localized oedema

4.1

181.2

605

1142

AN1

Coronary angiography

3.7

178.4

682

1422

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

18.7

177.9

179

N06AX21

ATC

duloxetine; oral

5.3

177.5

426

606

H02AB04

ATC

methylprednisolone; systemic

3.3

177.1

815

1925

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

5.6

177.1

398

531

N05CF01

ATC

zopiclone; oral

2.4

176.0

1704

6016

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

18.1

175.9

179

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

63.3

175.4

131

A10BB01

ATC

glibenclamide; oral

59.8

175.4

132

R03DC03

ATC

montelukast; oral

3.2

174.5

858

2112

SPAT1325

SPAT

Vaccination

2.4

174.2

1762

6341

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.3

174.0

815

1946

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

172.0

2200

8761

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

287.5

170.9

197

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

4.3

170.5

528

938

R42

ICD-10 Finland

Dizziness and giddiness

2.9

170.0

1002

2743

M54.9

ICD-10 Finland

Dorsalgia, unspecified

5.2

169.7

413

595

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

47.8

169.4

132

R03BA02

ATC

budesonide; inhalant

2.9

168.3

1001

2753

SPAT1229

SPAT

Assessment of need for aid

6.2

168.2

342

411

X59

ICD-10 Finland

Exposure to unspecified factor

3.2

167.9

850

2127

R51.80

ICD-10 Finland

Headache

4.2

167.3

540

991

WX723

NOMESCO Finland

CPAP therapy

348.6

167.0

191

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

4.7

167.0

465

756

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

9.3

166.9

243

192

M01AC06

ATC

meloxicam; systemic, rectal

2.4

166.3

1577

5492

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.7

166.0

639

1336

M47.9

ICD-10 Finland

Spondylosis, unspecified

35.5

165.6

137

L15

ICPC

Knee symptom/complaint

3.0

165.4

918

2425

R03AK07

ATC

formoterol and budesonide; inhalant

2.7

164.8

1122

3318

M81.9

ICD-10 Finland

Osteoporosis, unspecified

8.3

164.3

259

229

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.8

164.2

597

1198

A46

ICD-10 Finland

Erysipelas

3.3

164.1

753

1771

SPAT1254

SPAT

Administration of medicine

3.5

163.0

677

1491

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

162.9

1262

3985

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

21.7

162.9

155

WX002

NOMESCO Finland

Sedation and analgesia

2.9

162.6

996

2781

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

161.9

1581

5570

SPAT1222

SPAT

Counselling/guidance promoting independent living

3.4

161.5

698

1578

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

156.2

160.9

192

L01XE31

ATC

[U] nintedanib

+∞

160.7

176

E0000UV, ,

ATC

2.2

160.7

2073

8232

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

4.6

160.7

458

759

M79.0

ICD-10 Finland

Rheumatism, unspecified

58.3

160.2

121

M70.6

ICD-10 Finland

Trochanteric bursitis

4.3

160.2

485

845

OAB50, ,

SPAT

8.9

160.0

240

198

R99

ICPC

Respiratory disease other

15.1

159.7

176

M01AE03

ATC

ketoprofen; systemic, rectal

2.3

159.6

1766

6569

M01AX17

ATC

nimesulide; oral

2.7

159.5

1113

3329

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

5.4

158.9

372

516

R81

ICPC

Pneumonia

6.1

158.2

324

392

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

8.0

157.9

257

237

M02AA07

ATC

piroxicam; topical

2.3

157.8

1711

6304

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

27.2

157.1

139

L13

ICPC

Hip symptom/complaint

3.3

156.9

704

1630

ZX120

NOMESCO Finland

Intravenous

3.5

156.3

657

1457

M05BA07

ATC

risedronic acid; oral

9.5

156.2

224

173

WX780

NOMESCO Finland

Remote monitoring CPAP

1307.1

155.8

173

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.7

155.7

1128

3436

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.8

155.6

575

1166

WX408

NOMESCO Finland

General anesthesy, balanced

2.5

155.4

1367

4578

GX1K5

NOMESCO Finland

Diffusion capacity

32.7

155.4

131

R03BA05

ATC

fluticasone; inhalant

2.8

154.2

971

2746

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

5.7

153.3

339

444

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.2

152.6

2053

8256

A04

ICPC

Weakness/tiredness general

3.5

152.0

636

1405

M47.82

ICD-10 Finland

Other spondylosis, cervical region

18.5

151.8

153

SPAT1310

SPAT

Counselling related to known health issue

2.4

151.5

1429

4935

SPAT1301

SPAT

No procedures

2.4

151.0

1428

4937

D07AC01

ATC

betamethasone; topical

2.2

149.9

1847

7155

J01DA01

ATC

[U] cefalexin

2.1

149.5

3078

14550

N02BF02

ATC

pregabalin; oral

7.9

148.3

244

228

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.8

148.1

943

2679

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

147.9

162

R03BA01

ATC

beclometasone; inhalant

3.0

147.7

814

2133

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

9.5

147.6

212

164

A06AD11

ATC

lactulose; oral

3.0

147.6

798

2068

ZXA10

NOMESCO Finland

Bilateral

2.7

147.0

995

2919

J84.0

ICD-10 Finland

Alveolar and parietoalveolar conditions

+∞

147.0

161

SPAT1153

SPAT

Removal of sutures

2.4

146.6

1441

5059

M03BX02

ATC

tizanidine; oral

2.1

146.5

2727

12380

S97

ICPC

Chronic ulcer skin

6.0

145.8

303

372

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

145.7

1941

7744

M01AE02

ATC

naproxen; oral, rectal

2.1

145.5

2498

10994

TPH07

NOMESCO Finland

Cathetrisation of artery

3.2

145.5

705

1710

WX110

NOMESCO Finland

Infiltration anesthesia

2.1

144.5

3401

16811

L04AA01

ATC

[U] ciclosporin

23.1

144.0

134

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1194.7

143.9

160

M01AB05

ATC

diclofenac; systemic, rectal

2.1

143.6

3095

14795

H25.1

ICD-10 Finland

Senile nuclear cataract

2.3

143.1

1514

5482

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.2

142.7

348

501

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.4

141.9

605

1351

L90

ICPC

Osteoarthrosis of knee

7.8

141.5

234

220

M43.1

ICD-10 Finland

Spondylolisthesis

24.6

141.4

129

B01AF02

ATC

apixaban; oral

3.2

141.2

664

1579

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

21.6

140.7

134

A10AB01

ATC

insulin (human); parenteral

74.2

140.7

103

Z2221

NOMESCO Finland

Medical doctor

2.3

140.1

1462

5256

NH3EA

NOMESCO Finland

Feet X-ray examination with load

172.9

140.0

166

L08

ICPC

Shoulder symptom/complaint

2.7

139.7

931

2704

B01AF01

ATC

rivaroxaban; oral

3.6

139.1

536

1117

C03DA01

ATC

spironolactone; oral

3.2

138.9

649

1537

SPAT1249

SPAT

Treatment-related counselling outside office

2.2

138.8

1730

6694

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

14.6

138.7

155

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.9

138.5

824

2250

WW200

NOMESCO Finland

Immunization

6.9

138.5

253

269

48499

ICD-8 Finland

Acute interstitial pneumonia

+∞

137.8

151

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

229.9

136.4

159

T89

ICPC

Diabetes insulin dependent

41.4

136.2

109

R06AE07

ATC

cetirizine; oral

2.1

135.5

2070

8658

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

+∞

134.1

147

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

1101.1

133.8

149

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

27.5

133.8

118

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.5

133.4

538

1156

J01FA10

ATC

azithromycin; systemic

2.0

133.2

2696

12479

L04AB04

ATC

adalimumab; parenteral

19.1

132.6

132

M35.3

ICD-10 Finland

Polymyalgia rheumatica

9.0

132.6

197

160

E66.01

ICD-10 Finland

Obesity due to excess calories

6.2

132.5

267

317

A02BA02

ATC

ranitidine; systemic

2.6

132.3

1003

3103

SPAT1260

SPAT

Consultation of another employee

2.8

131.2

829

2335

N04BC05

ATC

pramipexole; oral

5.7

131.2

288

374

A10BD07

ATC

metformin and sitagliptin; systemic

537.0

131.1

148

205

Kela drug reimbursment

Chronic hypertension

2.3

130.0

1275

4442

GX1D5

NOMESCO Finland

Flow volume spirometry

69.1

130.0

ZXD05

NOMESCO Finland

Urgent procedure

2.2

130.0

1473

5459

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

13.9

129.5

148

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

9.3

129.3

188

148

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.3

129.3

1268

4417

207

Kela drug reimbursment

Chronic arrhythmias

2.7

129.0

829

2355

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.2

128.8

227

231

M09AX01

ATC

hyaluronic acid; parenteral

9.3

128.7

187

147

WZC30

NOMESCO Finland

Teaching

2.6

128.6

937

2839

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

12.7

128.4

154

SPAT1216

SPAT

Assessment of functional ability

3.1

128.3

633

1547

XF600

NOMESCO Finland

Bloodpressure measurement

4.6

127.9

356

576

A07AA02

ATC

nystatin; oral

4.3

127.8

388

675

Z94.2

ICD-10 Finland

Lung transplant status

352.4

127.6

146

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.1

126.7

634

1562

J46

ICD-10 Finland

Status asthmaticus

9.1

126.4

186

149

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

6.0

126.4

263

323

SPAT1256

SPAT

Intramuscular and subcutaneous injection

2.0

125.3

2062

8807

J43.9

ICD-10 Finland

Emphysema, unspecified

6.9

124.4

228

243

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.8

124.1

738

2008

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

124.0

136

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

60.8

123.8

R01AD09

ATC

mometasone; nasal

2.0

123.7

1996

8455

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

27.8

122.8

108

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

39.6

122.6

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

4.0

122.1

409

768

D64.9

ICD-10 Finland

Anaemia, unspecified

3.1

121.8

598

1455

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

121.2

613

1519

XX9XE

NOMESCO Finland

Other ultrasound examination

51.5

120.8

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

6.0

120.6

249

303

R28

ICPC

Limited function/disability (R)

12.7

120.3

144

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

3.9

119.8

418

809

M79.1

ICD-10 Finland

Myalgia

3.4

119.7

508

1127

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

+∞

119.4

131

C10AX09

ATC

ezetimibe; oral

2.8

119.2

714

1948

WZC00

NOMESCO Finland

Treatment plan or consultation

2.1

119.0

1773

7273

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.5

118.6

968

3090

JN4AD

NOMESCO Finland

Body CT examination

2.8

118.4

699

1892

A01

ICPC

Pain general/multiple sites

4.2

118.3

369

655

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

959.2

118.3

132

SPAT1255

SPAT

Intravenous administration of medicine

4.2

118.1

369

656

R5110, ,

SPAT

5.3

117.9

277

384

C10AA03

ATC

pravastatin; oral

4.0

117.5

395

743

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.9

117.4

678

1812

L04AD02

ATC

tacrolimus; systemic

23.1

117.3

109

XF402

NOMESCO Finland

ECG with work load test

3.2

116.7

557

1331

GDG10

NOMESCO Finland

Bilateral transplantation of lung

477.4

116.5

132

M01AB55

ATC

diclofenac, combinations; oral

4.9

116.2

300

454

XG474

NOMESCO Finland

Exhalation nntrogen oxide

7.5

115.7

197

192

ZX108

NOMESCO Finland

Inhalation

17.5

115.6

119

C07AB02

ATC

metoprolol; systemic

2.4

115.3

1030

3424

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

61.8

114.7

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

4.2

114.1

351

616

TDM10

NOMESCO Finland

Puncture of maxillary antrum

6.1

113.8

233

281

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

3.5

113.0

462

999

Angiography of the heart and coronary arteries

4.0

112.7

377

706

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

5.1

112.7

276

398

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

310.2

112.2

129

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

4.3

112.1

341

593

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

23.9

112.1

103

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

14.6

111.9

125

J20

ICD-10 Finland

Acute bronchitis

3.3

111.1

503

1162

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

15.9

110.9

119

M01CB01

ATC

sodium aurothiomalate; parenteral

232.0

110.7

129

Z50.1

ICD-10 Finland

Other physical therapy

6.2

110.4

223

265

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

7.3

110.3

191

190

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.8

109.7

384

744

Z2446

NOMESCO Finland

Social worker

4.1

109.1

355

651

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

226.4

108.0

126

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

4.6

107.7

296

473

C08CA02

ATC

felodipine; oral

3.2

107.7

505

1192

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.8

106.8

282

435

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

106.6

117

M03BC01

ATC

orphenadrine (citrate); systemic

2.5

106.6

826

2563

XW000

NOMESCO Finland

Bone marrow biopsy

4.5

106.1

299

488

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

4.0

106.0

354

662

A10BJ06

ATC

semaglutide; parenteral

+∞

105.7

116

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

4.7

105.6

287

454

B01AX06

ATC

[U] rivaroxaban

49.1

105.6

E66.00

ICD-10 Finland

Metabolic syndrome

7.0

105.6

190

198

A03

ICPC

Fever

2.6

104.9

735

2170

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.6

104.7

760

2283

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

7.8

104.2

171

159

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

220.0

103.5

121

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

18.0

103.2

105

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

11.4

103.1

131

R07.3

ICD-10 Finland

Other chest pain

3.3

103.1

466

1074

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.5

102.8

796

2466

Z3229

NOMESCO Finland

Other healthcare associate professional

3.3

102.8

453

1027

R06.2

ICD-10 Finland

Wheezing

4.9

102.8

260

386

L04AB01

ATC

etanercept; parenteral

218.1

102.6

120

N03AE01

ATC

clonazepam; systemic

5.7

101.6

220

281

M54.1

ICD-10 Finland

Radiculopathy

11.0

101.5

132

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

15.1

101.1

111

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

24.5

100.8

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

3.6

100.8

387

800

M10.0

ICD-10 Finland

Idiopathic gout

7.9

100.6

164

151

E66.8

ICD-10 Finland

Other obesity

7.5

100.6

170

164

R03AC13

ATC

formoterol; inhalant

4.2

100.6

314

557

J01FA09

ATC

clarithromycin; systemic

2.0

100.5

1444

5784

N05BA04

ATC

oxazepam; oral

2.2

100.4

1106

3999

G56.2

ICD-10 Finland

Lesion of ulnar nerve

16.8

100.3

105

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

10.7

100.2

132

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.8

100.1

356

697

A01AB09

ATC

miconazole; local oral

3.2

99.9

466

1095

XCK10

NOMESCO Finland

Photography of fundus of eye

3.5

99.8

392

823

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.4

99.7

418

917

ZXE20

NOMESCO Finland

More than three and less than five hours

2.6

99.7

712

2119

WX721

NOMESCO Finland

Oxygen concentrator therapy

50.2

99.5

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

170.6

99.5

118

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.1

99.4

485

1171

212

Kela drug reimbursment

Gout

+∞

99.3

109

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

800.8

99.1

111

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.2

99.1

456

1062

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.6

98.6

703

2090

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.3

98.5

929

3145

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

16.1

98.5

105

L86

ICPC

Back syndrome with radiating pain

5.5

98.1

223

299

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

208.6

98.1

115

SPAT1097

SPAT

Recording of ECG

2.6

97.9

689

2035

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

97.5

107

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.4

97.1

285

481

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

4.6

96.7

267

428

R05FB02

ATC

cough suppressants and expectorants; systemic

1.9

96.7

1805

7899

XF404

NOMESCO Finland

Ambulatory ECG

3.2

96.5

441

1022

S22.3

ICD-10 Finland

Fracture of rib

3.8

96.4

345

678

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

778.7

96.4

108

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.8

96.3

561

1500

J45.8

ICD-10 Finland

Mixed asthma

6.0

96.2

198

240

C08CA05

ATC

nifedipine; systemic

3.7

96.0

354

711

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

14.0

95.9

109

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

33.8

95.6

L89

ICPC

Osteoarthrosis of hip

11.8

95.4

119

R52.9

ICD-10 Finland

Pain, unspecified

3.6

95.4

370

770

D86.0

ICD-10 Finland

Sarcoidosis of lung

9.6

95.3

135

102

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.2

94.8

292

512

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

94.7

104

R03AC03

ATC

terbutaline; inhalant

2.6

94.7

662

1947

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

21.6

94.6

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.9

94.5

1654

7074

C09CA01

ATC

losartan; oral

2.1

94.1

1203

4598

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

93.6

513

1325

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

93.5

1364

5472

WX725

NOMESCO Finland

Noninvasive ventilation

3.9

93.5

315

592

G20

ICD-10 Finland

Parkinson disease

51.6

93.5

NA1AD

NOMESCO Finland

Cervical spine CT examination

6.8

93.5

172

184

W19

ICD-10 Finland

Unspecified fall

3.3

93.4

407

915

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

3.5

93.3

367

771

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.7

93.2

344

691

M20.2

ICD-10 Finland

Hallux rigidus

31.5

92.9

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

9.9

92.7

128

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

34.5

92.5

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

+∞

92.0

101

72410

ICD-8 Finland

Internal derangement of joint, Other shoulder derangement

+∞

92.0

101

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

92.0

980

3484

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.7

91.4

571

1584

H03AA01

ATC

levothyroxine sodium; systemic

2.2

91.4

984

3513

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

13.1

90.8

107

NBG10

NOMESCO Finland

Acromioplastia

26.4

90.8

N17.9

ICD-10 Finland

Acute renal failure, unspecified

4.7

90.8

244

382

R55

ICD-10 Finland

Syncope and collapse

2.9

90.7

513

1348

N18.8

ICD-10 Finland

Other chronic renal failure

7.7

90.1

150

142

R06.5

ICD-10 Finland

Mouth breathing

3.8

90.0

316

612

N05AH04

ATC

quetiapine; oral

2.7

90.0

587

1665

J45

ICD-10 Finland

Asthma

3.0

89.8

474

1197

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

154.4

89.6

107

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

12.9

89.5

106

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.1

89.4

284

510

Z71.8

ICD-10 Finland

Other specified counselling

2.0

89.2

1277

5077

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

14.0

88.7

101

SAA03

NOMESCO Finland

Extended examination of mouth

1.9

88.4

1658

7226

M54.3

ICD-10 Finland

Sciatica

5.8

88.3

188

236

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.1

88.2

1043

3859

N06AX16

ATC

venlafaxine; oral

2.9

87.9

487

1264

G04CA02

ATC

tamsulosin; oral

2.0

87.6

1327

5379

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

15.0

87.3

M05BX04

ATC

denosumab; parenteral

3.6

87.3

338

702

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

9.2

86.7

126

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

3.3

86.5

383

869

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

+∞

86.5

R01AD08

ATC

fluticasone; nasal

2.0

86.5

1251

4986

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

11.3

86.3

110

SPAT1053

SPAT

Memory test

2.6

86.2

610

1801

C08CA13

ATC

lercanidipine; oral

2.6

86.1

609

1798

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

85.8

691

2170

A10AE06

ATC

insulin degludec; parenteral

690.6

85.5

L29

ICPC

Musculoskeletal sympt/complt other

3.5

85.1

333

696

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.3

84.3

368

827

J96.0

ICD-10 Finland

Acute respiratory failure

8.6

84.3

128

107

N06AB04

ATC

citalopram; systemic

2.2

84.3

830

2848

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

5.1

84.2

203

288

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

20.8

84.1

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.2

83.9

386

897

UKC02

NOMESCO Finland

Cystoscopy

2.2

83.8

821

2810

SPAT1211

SPAT

Application of soft bandage

3.3

83.8

369

834

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

675.9

83.7

L40.5

ICD-10 Finland

Arthropathic psoriasis

31.8

83.7

R96

ICPC

Asthma

3.1

83.5

412

999

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

144.1

83.4

100

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.7

83.1

298

586

I25.2

ICD-10 Finland

Old myocardial infarction

3.1

82.9

398

949

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.9

82.7

446

1139

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.9

82.7

443

1127

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.7

82.4

297

586

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

82.0

548

1571

J01FA15

ATC

telithromycin; oral

2.8

82.0

491

1329

P06

ICPC

Sleep disturbance

3.1

81.6

392

935

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.2

81.6

382

897

J02AC01

ATC

fluconazole; systemic

1.9

81.6

1581

6931

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

20.2

81.2

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

333.5

81.1

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

3.5

81.1

319

669

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

654.0

80.9

D07AC13

ATC

mometasone; topical

1.9

80.8

1367

5732

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

80.4

390

936

M72.0

ICD-10 Finland

Palmar fascial fibromatosis [Dupuytren]

10.0

80.2

110

X58

ICD-10 Finland

Exposure to other specified factors

2.6

80.2

533

1523

R29

ICPC

Respiratory symptom/complaint other

3.5

80.1

320

678

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

80.1

H02AB09

ATC

hydrocortisone; systemic

7.1

80.1

141

143

GX2C5

NOMESCO Finland

Short-lasting oximetry

26.8

79.9

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.6

79.9

562

1652

XA402

NOMESCO Finland

ENMG

20.0

79.8

R13

ICD-10 Finland

Dysphagia

3.6

79.8

307

634

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

5.2

79.8

191

269

NHK30

NOMESCO Finland

Osteotomy or rotation osteotomy of first metatarsal or tarsal bone

224.5

79.7

WZA10

NOMESCO Finland

Extensive medical or dental certificate

10.6

79.5

105

M50.3

ICD-10 Finland

Other cervical disc degeneration

20.5

79.5

M10

ICD-10 Finland

Gout

4.6

79.2

219

351

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

6.7

79.1

147

159

I50.1

ICD-10 Finland

Left ventricular failure

3.8

78.9

277

536

WX872

NOMESCO Finland

Intensive care

3.4

78.9

320

685

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.4

78.9

330

721

P20

ICPC

Memory disturbance

2.7

78.9

492

1360

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

10.5

78.8

105

P01AB01

ATC

metronidazole; oral, rectal

1.8

78.7

1735

7899

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.5

78.6

306

637

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

6.3

78.5

154

177

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

322.5

78.4

G51.0

ICD-10 Finland

Bell palsy

22.7

78.2

R01AD12

ATC

fluticasone furoate; nasal

1.9

77.7

1256

5177

E000001, ,

ATC

2.1

77.4

883

3208

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.6

77.4

534

1554

Z51.5

ICD-10 Finland

Palliative care

2.6

77.0

534

1558

SPAT1305

SPAT

Counselling and guidance related to physical exercise

3.3

76.9

330

733

WZA90

NOMESCO Finland

Other medical or dental certificate

2.1

76.9

889

3246

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.2

76.7

770

2656

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.0

76.7

191

279

I20.09

ICD-10 Finland

Unstable angina

3.6

76.5

293

603

NG1DA

NOMESCO Finland

X-ray of knees

77.6

76.3

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

76.3

2406

12105

H03BB01

ATC

carbimazole; oral

13.9

76.2

M79.7

ICD-10 Finland

Fibromyalgia

14.5

76.2

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.5

76.1

544

1610

SPAT1312

SPAT

General health counselling

1.9

76.1

1308

5497

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

31.0

76.1

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

5.7

75.9

164

209

L95

ICPC

Osteoporosis

4.8

75.9

197

299

S29

ICPC

Skin symptom/complaint other

2.1

75.7

835

2991

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

6.7

74.9

139

150

B01AB04

ATC

dalteparin; parenteral

3.8

74.9

266

519

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

74.8

2820

14857

250, ,

Kela drug reimbursment

30.5

74.6

A10BG03

ATC

pioglitazone; oral

+∞

74.6

R52.2

ICD-10 Finland

Other chronic pain

7.5

74.3

126

122

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

209.4

74.3

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.3

74.2

320

713

K02.1

ICD-10 Finland

Caries of dentine

1.7

74.1

2499

12771

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.3

74.1

325

732

N03AF01

ATC

carbamazepine; oral, rectal

5.2

74.0

174

241

J80

ICD-10 Finland

Adult respiratory distress syndrome

21.8

73.9

WX111

NOMESCO Finland

Local infiltration anesthesia

83.6

73.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.4

73.8

302

650

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

2.9

73.7

411

1068

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.9

73.7

400

1024

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

73.5

1111

4466

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

3.2

73.5

339

788

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

5.9

73.3

153

188

L16

ICPC

Ankle symptom/complaint

2.9

73.3

405

1047

WX882

NOMESCO Finland

High dependency care

5.5

73.3

165

219

A10AA02, ,

ATC

93.5

73.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.6

72.7

489

1403

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

126.5

72.7

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

126.5

72.7

L01

ICPC

Neck symptom/complaint

2.5

72.4

555

1698

L12

ICPC

Hand/finger symptom/complaint

2.4

72.2

577

1799

N05CD07

ATC

temazepam; oral

2.4

72.2

581

1818

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

19.6

72.1

NG2AA

NOMESCO Finland

Patella X-ray examination

19.6

72.1

B02.9

ICD-10 Finland

Zoster without complication

2.9

72.0

378

949

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

71.7

3140

17131

XX2RW, ,

NOMESCO Finland

8.3

71.3

111

R04.0

ICD-10 Finland

Epistaxis

2.9

70.7

378

959

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

4.1

70.4

223

399

N03AF02

ATC

oxcarbazepine; oral

15.6

70.3

R11

ICD-10 Finland

Nausea and vomiting

3.1

70.0

343

827

I95.1

ICD-10 Finland

Orthostatic hypotension

5.4

70.0

159

213

M03BC51

ATC

orphenadrine, combinations; systemic

2.0

69.9

1030

4097

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

5.3

69.7

161

219

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.5

69.7

132

146

M54.6

ICD-10 Finland

Pain in thoracic spine

4.0

69.6

225

409

GD2SN

NOMESCO Finland

Lung ventilation SPECT

17.2

69.5

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

37.0

69.5

Z96.1

ICD-10 Finland

Presence of intraocular lens

2.2

69.4

671

2273

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

15.1

69.4

NF1DA

NOMESCO Finland

X-ray of hips

149.0

69.4

J05AB11

ATC

valaciclovir; oral

2.2

69.4

708

2453

J31.0

ICD-10 Finland

Chronic rhinitis

3.0

69.2

347

848

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.0

69.1

228

421

XJC10

NOMESCO Finland

Oesophageal pH monitoring

22.2

69.0

I50

ICD-10 Finland

Heart failure

5.2

69.0

162

224

M02AA10

ATC

ketoprofen; topical

2.3

68.9

630

2084

M05BB03

ATC

alendronic acid and colecalciferol; oral

6.3

68.9

135

155

C09AA02

ATC

enalapril; systemic

2.1

68.9

856

3202

M01AB01

ATC

indometacin; systemic, rectal

3.0

68.8

342

831

R20.2

ICD-10 Finland

Paraesthesia of skin

3.9

68.8

233

439

NHQ40

NOMESCO Finland

Amputation of toe

14.0

68.6

M17.5

ICD-10 Finland

Other secondary gonarthrosis

30.1

68.6

G40.9

ICD-10 Finland

Epilepsy, unspecified

282.3

68.5

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.7

68.5

1939

9400

R4130

NOMESCO Finland

Speech therapy

6.7

68.3

126

135

H04.10

ICD-10 Finland

Dry eye syndrome

2.5

68.3

489

1446

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.2

68.3

310

713

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.2

68.3

303

687

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

68.2

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

551.8

68.2

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

14.2

68.2

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

5.2

67.8

161

225

J05AB01

ATC

aciclovir; systemic

2.0

67.6

981

3877

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

+∞

67.3

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

16.4

67.2

R03AK11

ATC

formoterol and fluticasone; inhalant

5.4

66.9

151

201

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.7

66.4

414

1141

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

+∞

66.4

C03AA03

ATC

hydrochlorothiazide; oral

2.8

66.3

373

973

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

3.7

66.2

235

458

SFA10

NOMESCO Finland

One-surface restoration

1.7

66.2

2301

11746

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.3

66.2

288

645

K78

ICPC

Atrial fibrillation/flutter

2.9

65.5

355

907

JN4BD

NOMESCO Finland

Extensive body CT

2.2

65.4

661

2278

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

4.0

65.4

215

396

D11

ICPC

Diarrhoea

2.6

65.4

424

1193

XA800

NOMESCO Finland

Neuropsychological investigation

7.3

65.3

112

110

1220

FHL

Arthroscopy

7.3

65.3

112

110

TK800

NOMESCO Finland

Hemodialysis

7.0

65.3

116

119

A10AB04

ATC

insulin lispro; parenteral

67.1

65.0

9211

FHL

Exploration or removal of diskusprolapse

267.7

64.9

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

6.1

64.9

130

153

R05FA02

ATC

opium derivatives and expectorants; systemic

1.7

64.8

1793

8608

R03AC12

ATC

salmeterol; inhalant

3.2

64.8

286

646

K07

ICPC

Swollen ankles/oedema

4.2

64.7

199

348

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

6.6

64.6

121

132

M54

ICD-10 Finland

Dorsalgia

2.6

64.6

421

1187

R04

ICPC

Breathing problem other

4.9

64.6

163

241

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

3.7

64.4

234

464

A11

ICPC

Chest pain NOS

2.8

64.2

363

949

NFB50

NOMESCO Finland

Primary total prosthetic replacement of hip joint using cement

28.6

64.2

WX204

NOMESCO Finland

Axillary plexus blockaced

5.8

64.1

136

170

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

3.5

63.9

249

518

N19

ICD-10 Finland

Unspecified kidney failure

4.4

63.9

183

302

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.1

63.5

199

353

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

5.6

63.1

138

178

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

5.7

63.0

136

173

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

5.9

62.9

130

158

A41.9

ICD-10 Finland

Sepsis, unspecified

4.1

62.9

194

340

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.8

62.8

221

428

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

62.8

J92.9

ICD-10 Finland

Pleural plaque without asbestos

7.2

62.6

109

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

12.0

62.6

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

256.7

62.2

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

7.1

62.2

109

110

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.9

62.1

330

833

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

7.6

62.1

103

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.5

62.0

439

1290

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

36.4

61.9

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

+∞

61.9

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

4.9

61.8

155

228

M54.2

ICD-10 Finland

Cervicalgia

3.7

61.6

218

424

N17

ICPC

Vertigo/dizziness

2.5

61.0

450

1348

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

11.9

60.8

A08

ICPC

Swelling

3.9

60.7

201

372

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

10.6

60.6

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

7.4

60.6

103

100

XG405

NOMESCO Finland

Education on PEF monitoring

7.1

60.6

107

109

R5599

NOMESCO Finland

Other rehabilitation service

6.8

60.5

110

116

C10AA04

ATC

fluvastatin; oral

2.7

60.4

361

972

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

4.3

60.4

180

307

GDA10

NOMESCO Finland

Biopsy of lung

24.6

60.3

G04BD12

ATC

mirabegron; oral

2.5

60.2

452

1365

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.9

60.2

319

804

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

13.2

59.9

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.2

59.9

603

2072

D72.1

ICD-10 Finland

Eosinophilia

17.1

59.7

SPAT1104

SPAT

Monitoring of emergency patient

3.2

59.6

274

635

Z01.2

ICD-10 Finland

Dental examination

1.7

59.5

1829

8983

M01AX01

ATC

nabumetone; oral

4.5

59.5

164

262

N30.0

ICD-10 Finland

Acute cystitis

2.2

59.4

575

1943

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

30.3

59.3

GX2D5

NOMESCO Finland

Sleep oximetry

30.3

59.3

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

3.1

59.3

285

678

L02

ICPC

Back symptom/complaint

2.8

59.3

332

863

K90

ICPC

Stroke/cerebrovascular accident

88.4

59.2

R74

ICPC

Upper respiratory infection acute

1.8

59.1

1112

4761

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

+∞

59.1

K77

ICPC

Heart failure

6.7

59.0

109

117

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

10.8

59.0

XX4BW, ,

NOMESCO Finland

68.2

59.0

XQ800

NOMESCO Finland

Prick test

3.0

58.9

291

704

-1, ,

NOMESCO Finland

1.7

58.9

1311

5900

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

127.2

58.7

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.1

58.6

280

664

Z02.7

ICD-10 Finland

Issue of medical certificate

3.3

58.6

254

567

N03AX14

ATC

levetiracetam; systemic

11.6

58.3

C02AC05

ATC

moxonidine; oral

4.6

58.3

156

243

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

471.8

58.3

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

+∞

58.2

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

+∞

58.2

N02AA01

ATC

morphine; systemic, rectal

4.1

58.2

179

313

R60.9

ICD-10 Finland

Oedema, unspecified

3.6

58.2

217

438

XG460

NOMESCO Finland

Short time oxymetry

5.6

58.0

127

164

WX200

NOMESCO Finland

Interscalenous plexus blockade

11.0

58.0

M19.9

ICD-10 Finland

Arthrosis, unspecified

5.3

57.9

133

180

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

8.4

57.7

NDM20

NOMESCO Finland

Excision of synovial ganglion of wrist or hand

31.8

57.7

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.8

57.6

201

387

SPAT1058

SPAT

PEF monitoring instruction

2.8

57.5

331

873

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.7

57.5

206

404

N02AJ13

ATC

tramadol and paracetamol; systemic

11.0

57.4

N05BA01

ATC

diazepam; systemic, rectal

2.3

57.4

524

1727

J43.8

ICD-10 Finland

Other emphysema

15.0

57.4

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

+∞

57.3

TNG10

NOMESCO Finland

Puncture of knee

+∞

57.3

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.0

57.2

284

689

K29.3

ICD-10 Finland

Chronic superficial gastritis

4.6

57.0

153

239

B01AB10

ATC

tinzaparin; parenteral

2.4

57.0

450

1391

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

123.6

57.0

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

56.9

4301

26134

Z01.9

ICD-10 Finland

Special examination, unspecified

3.3

56.8

248

556

A10BH02

ATC

vildagliptin; oral

234.9

56.8

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

6.0

56.5

116

140

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

457.3

56.4

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

5.1

56.4

135

190

C10AA07

ATC

rosuvastatin; oral

1.7

56.4

1314

5979

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

11.2

56.4

U04

ICPC

Incontinence urine

3.9

56.3

191

360

D07AB08

ATC

desonide; topical

2.3

56.2

489

1578

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.2

56.1

249

564

D07XC01

ATC

betamethasone; topical

2.2

56.1

567

1949

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.9

56.1

187

348

SPAT1059

SPAT

Spirometry at the office

3.4

56.0

231

499

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.8

55.9

1069

4591

G30.1

ICD-10 Finland

Alzheimer disease with late onset

5.1

55.8

135

192

G04BD08

ATC

solifenacin; oral

3.0

55.8

276

668

A29

ICPC

General symptom/complaint other

2.3

55.7

508

1673

C01AA05

ATC

digoxin; systemic

2.4

55.6

425

1293

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

+∞

55.5

L04AA24

ATC

abatacept; parenteral

+∞

55.5

SPAT1281

SPAT

Other administrative function

2.8

55.4

307

793

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.0

55.4

275

667

J12.8

ICD-10 Finland

Other viral pneumonia

7.6

55.3

B01AC07

ATC

dipyridamole; systemic

4.0

55.2

179

326

NDM10

NOMESCO Finland

Palmar fasciotomy of hand

227.6

55.0

A10AA01, ,

ATC

97.4

55.0

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

28.5

55.0

NDG76

NOMESCO Finland

Fusion of DIP joint

28.5

55.0

J01DA09

ATC

[U] cefadroxil

1.8

54.9

1095

4760

SPAT1377

SPAT

Polysomnography

5.8

54.9

115

142

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.7

54.8

342

942

M65.3

ICD-10 Finland

Trigger finger

5.4

54.7

123

163

SPAT1252

SPAT

Overall medication plan or its review

3.0

54.6

272

661

A10BJ02

ATC

liraglutide; parenteral

57.4

54.6

K29.7

ICD-10 Finland

Gastritis, unspecified

4.2

54.5

164

282

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.5

54.4

120

156

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

17.4

54.4

R1250

NOMESCO Finland

Evaluation of functional capability

8.5

54.3

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

3.1

54.3

256

602

I27.8

ICD-10 Finland

Other specified pulmonary heart diseases

15.9

54.3

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

3.2

54.2

242

550

SPAT1215

SPAT

Assessment of need for medical rehabilitation

5.0

54.2

132

189

D01

ICPC

Abdominal pain/cramps general

2.4

54.1

412

1251

XX1XW

NOMESCO Finland

Extensive written report from radiologist

5.0

54.1

133

192

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

4.1

54.1

167

293

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

3.7

54.1

194

381

R4180

NOMESCO Finland

Podiatric therapy

17.9

54.0

D07AD01

ATC

clobetasol; topical

2.0

53.9

725

2774

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.1

53.9

255

601

EBA00

NOMESCO Finland

Extraction of tooth

1.7

53.8

1438

6777

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.2

53.7

247

572

B01AE07

ATC

dabigatran etexilate; oral

3.9

53.6

178

330

73799

ICD-8 Finland

Hallux valgus and varus

+∞

53.6

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

+∞

53.6

TFP20

NOMESCO Finland

Cardiodefibrillation

2.6

53.6

364

1046

TKC20

NOMESCO Finland

Catheterisation of bladder

2.6

53.5

342

953

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

53.5

3058

17255

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.9

53.4

808

3218

E66.9

ICD-10 Finland

Obesity, unspecified

7.4

53.2

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

53.0

732

2825

N06DX01

ATC

memantine; oral

3.8

53.0

182

346

SPAT1202

SPAT

Intra-articular injection

5.9

53.0

109

132

5BA08, ,

NOMESCO Finland

14.5

53.0

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

15.7

52.9

I25

ICD-10 Finland

Chronic ischaemic heart disease

3.2

52.8

242

559

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

428.4

52.8

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3015377) Calcium [Moles/volume] in Serum or Plasma

2310

7402

3.04

322.40

4.4

4.5

2.34

2.36

mmol/l

5.55

2106

6570

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2435

8079

2.98

318.88

3.4

2.2

200.85

153.92

ug/l

5.93

2235

7501

(40758558) Short blood count panel - Blood

1970

5781

3.16

318.82

11.2

7.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

431

310

10.57

316.88

4.7

2.8

25.37

24.86

mmol/l

0.87

416

300

(3024139) IgG subclass 3 [Mass/volume] in Serum

310

116

19.95

314.45

1.5

1.2

0.49

0.46

g/l

0.23

214

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

298

100

22.21

314.38

2.1

1.4

—

(4062490) Immunoglobulin typing, IgG

309

115

20.06

314.07

1.5

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

311

118

19.68

313.80

1.5

1.2

7.55

7.00

g/l

0.76

213

(3028192) IgG subclass 2 [Mass/volume] in Serum

310

117

19.78

313.42

1.5

1.2

2.96

3.22

g/l

0.64

214

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

757

1115

5.39

308.75

1.9

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1842

1667

11.10

307.65

1.3

1.1

23.69

1.38

u/ml

7.97

541

644

(3006504) Eosinophils/100 leukocytes in Blood

4038

9419

8.05

307.65

12.7

4.6

2.82

2.88

0.68

3961

8704

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2537

7084

3.78

307.65

5.0

2.5

104.45

61.68

ng/l

0.28

2007

4533

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

776

232

27.27

307.65

1.9

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1256

2317

4.64

307.65

2.9

1.9

21.22

24.20

8.08

1072

2002

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

932

1582

4.79

307.65

4.1

2.3

211.49

225.50

ng/l

0.31

869

1458

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

645

216

23.72

307.65

1.3

1.1

3.82

2.23

u/ml

—

(3037522) Nuclear Ab [Titer] in Serum

2216

1530

16.18

307.65

1.5

1.2

599.57

429.73

titre

2.15

657

257

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

647

274

18.74

307.65

1.8

1.2

0.23

0.24

g/l

1.24

624

251

(3042631) Mycobacterium sp identified in Specimen

577

255

17.72

307.65

2.9

2.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

529

196

20.97

307.65

2.7

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

2203

5906

3.68

307.65

4.7

2.6

0.34

0.61

e6/l

4.32

1754

4225

(3022217) INR in Platelet poor plasma by Coagulation assay

3327

9360

4.66

307.65

17.4

11.7

1.25

1.29

inr

1.47

1126

2511

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

319

27.76

307.65

1.3

1.2

—

u/ml

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3045

9146

3.93

307.65

6.6

4.8

33.69

35.07

g/l

27.65

2855

8470

(3021601) Nitrite [Presence] in Urine by Test strip

2969

10145

3.25

307.65

6.6

3.6

0.00

estimate

0.80

827

1729

(3021589) Normoblasts [#/volume] in Blood

3204

10140

3.84

307.65

19.3

7.2

0.00

e9/l

0.01

2747

8047

(3024980) IgG subclass 4 [Mass/volume] in Serum

392

225

13.17

307.65

1.7

1.3

0.92

g/l

0.01

284

165

(3018418) pH of Serum or Plasma

2518

5781

4.74

307.65

5.7

3.5

7.40

0.23

613

1035

(3027801) Oxygen [Partial pressure] in Arterial blood

1506

2042

6.74

307.65

9.7

7.3

10.27

13.34

kpa

71.06

1445

1936

(3022096) Basophils/100 leukocytes in Blood

4001

9092

8.16

307.65

12.6

4.6

0.65

0.68

2.81

3927

8369

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

472

202.37

307.65

1.1

—

(3000492) Spirometry study

1205

1952

5.28

307.65

2.8

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2337

7351

3.13

307.65

2.1

1.6

92.30

94.51

pmol/l

1.22

1265

3612

(3013115) Eosinophils [#/volume] in Blood

4325

10185

9.42

307.65

12.9

4.7

0.21

0.19

e9/l

12.86

4005

8624

(3008152) Bicarbonate [Moles/volume] in Arterial blood

742

976

6.04

307.65

8.6

6.6

24.98

24.61

mmol/l

1.41

713

922

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

872

413

17.48

307.65

2.4

1.5

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3784

11785

4.82

307.65

10.1

7.5

11.07

13.09

umol/l

10.95

3676

11231

(3004616) Nuclear Ab [Presence] in Serum

315

26.47

307.65

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

660

248

21.19

307.65

1.3

1.1

38.78

4.09

u/ml

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

739

112

53.55

307.65

2.1

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

541

267

15.75

307.65

1.2

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

975

1626

4.92

307.65

12.1

5.2

10.34

9.00

mmol/l

5.44

937

1559

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

572

209

21.43

307.65

1.8

1.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

4056

9794

7.76

307.65

12.9

4.6

25.06

28.06

44.57

3980

9096

(3019069) Monocytes/100 leukocytes in Blood

4043

9475

8.02

307.65

13.2

4.9

8.86

8.81

0.34

3966

8763

(3017181) Myelocytes/100 leukocytes in Blood

1206

1382

7.57

307.65

6.0

3.5

0.86

1.04

1.03

529

528

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1487

3254

4.03

307.65

7.0

3.8

0.81

0.82

mmol/l

4.88

1398

3088

(3015171) Extractable nuclear Ab [Units/volume] in Serum

875

335

21.68

307.65

1.3

1.1

2.08

0.80

u/ml

1.10

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

836

766

8.89

307.65

6.1

3.9

5.14

5.09

kpa

0.62

803

715

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2205

4059

5.65

307.65

3.6

1.7

157.92

201.12

u/l

2.25

2085

3747

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1297

2474

4.51

307.65

2.8

1.9

2.27

2.29

g/l

0.63

1206

2292

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

985

383

21.82

307.65

1.7

1.4

324.15

149.33

titre

1.21

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1279

608

18.93

307.65

3.1

2.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2308

6897

3.31

307.65

5.3

3.3

34.89

38.90

u/l

0.68

2210

6587

(3035350) Ketones [Presence] in Urine by Test strip

2982

10023

3.33

307.65

4.9

2.6

0.00

estimate

0.80

857

1814

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

416

260

12.14

307.65

5.1

2.1

703.70

1084.54

u/ml

0.24

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1184

2212

4.52

307.65

8.1

4.7

1.05

1.02

mmol/l

2.85

1108

2071

(3001604) Monocytes [#/volume] in Blood

4264

9775

9.39

307.65

12.1

4.5

0.66

0.59

e9/l

38.15

3909

8134

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

670

655

8.08

307.65

2.5

1.8

2.23

2.49

ug/l

0.10

610

585

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

701

303

18.54

307.65

2.4

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1073

2058

4.32

307.65

3.6

2.4

1.94

1.65

10.82

962

1838

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

865

392

18.25

307.65

2.4

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3986

15098

3.92

307.65

6.8

3.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

351

26.96

307.65

1.3

1.1

54.91

5.54

u/ml

—

(3026782) Osmolality of Urine

1712

4132

3.77

307.65

4.0

2.4

525.74

560.93

mosm/kgh2o

8.98

1543

3513

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

549

404

10.54

307.65

1.8

2.1

10.80

10.91

mg/l

0.08

514

381

(3006184) Hemoglobin [Mass/volume] in Capillary blood

619

344

14.17

307.65

2.5

1.8

128.05

130.54

g/l

0.68

261

250

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

707

209

27.21

307.65

2.1

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

812

268

24.86

307.65

2.1

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1056

880

10.21

307.65

2.2

2.0

1.13

1.44

g/l

2.13

986

790

(3022313) Gas panel - Capillary blood

555

548

7.84

307.65

6.5

4.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3722

11893

4.53

307.65

8.7

3.7

6.76

6.25

mmol/l

47.20

3586

11040

(3013650) Neutrophils [#/volume] in Blood by Automated count

4356

12518

7.29

307.65

16.2

9.3

4.66

3.96

e9/l

53.52

4039

10614

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

464

303

11.72

307.65

1.6

1.5

60.17

6.84

iu/ml

0.87

103

(3019198) Lymphocytes [#/volume] in Blood

4283

10116

9.13

307.65

12.3

4.5

1.90

1.96

e9/l

0.73

3968

8640

(3019060) Gas panel - Arterial blood

1143

1023

9.65

307.65

4.8

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

427

180

18.08

307.65

2.7

1.3

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

580

292

15.55

307.65

2.5

1.5

—

(3023368) Bacteria identified in Blood by Culture

2645

5209

5.86

307.65

6.1

3.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

573

344

13.00

307.65

12.2

3.9

1535.77

367.49

iu/ml

0.54

132

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

814

736

8.97

307.65

5.9

3.8

2.20

1.89

mmol/l

0.88

646

531

(3005322) IgE [Units/volume] in Serum or Plasma

943

938

8.34

307.65

1.6

1.2

247.43

299.20

u/ml

0.52

877

865

(3002582) Erythrocytes [#/volume] in Urine

2376

6548

3.70

307.65

4.9

2.7

35.52

117.91

e6/l

3.49

1929

4762

(3000850) Epithelial cells [#/volume] in Urine

1775

4134

3.97

307.65

3.8

2.2

4.38

5.48

e6/l

1.76

1635

3645

(36304419) Bacteria [Presence] in Urine

2176

5742

3.73

307.65

4.7

2.6

—

(3042936) Bacteria identified in Isolate by Culture

1547

2348

6.04

307.65

2.5

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1617

1756

8.72

307.65

2.7

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

805

1017

6.36

307.65

11.8

9.5

24.69

24.31

mmol/l

1.93

773

975

(3036481) Cortisol [Moles/volume] in Serum or Plasma

946

1218

6.40

307.65

2.2

3.1

334.77

400.47

nmol/l

10.33

893

1151

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4610

18446

5.09

307.65

14.8

7.0

78.03

82.17

u/l

6.72

4517

17181

(3016502) Oxygen saturation in Arterial blood

1261

1782

6.15

307.65

10.6

7.9

93.89

96.02

16.35

1216

1715

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2054

2652

8.02

307.65

2.8

1.6

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1508

2045

6.75

307.65

9.7

7.3

5.03

5.12

kpa

2.30

1445

1939

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

395

162

18.48

307.65

3.5

3.2

—

(3003396) Base excess in Arterial blood by calculation

1496

2043

6.68

307.65

9.7

7.3

1.38

0.90

mmol/l

3.33

1247

1644

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3435

9250

5.12

307.65

9.9

5.0

1.21

mmol/l

5.67

3251

8308

(3018010) Neutrophils/100 leukocytes in Blood

4021

9582

7.76

307.65

12.3

4.5

59.92

56.65

43.04

3940

8888

(3018095) Leukocytes [#/volume] in Urine

2589

7544

3.63

307.65

5.9

3.0

96.38

116.92

e6/l

0.35

1992

5110

(3023419) Bacteria identified in Sputum by Culture

691

234

23.66

307.65

2.7

2.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

772

813

7.62

307.65

2.1

2.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1122

1255

7.64

307.65

5.9

3.5

0.58

0.70

0.81

472

469

(3005719) IgG [Mass/volume] in Serum or Plasma

1341

1042

11.62

307.65

4.2

2.6

10.28

10.84

g/l

2.12

1281

946

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1045

1713

5.07

307.65

12.2

7.8

123.58

120.26

g/l

4.00

1015

1663

(3020682) Albumin/Creatinine [Ratio] in Urine

1878

3936

4.55

307.65

4.3

2.0

11.13

5.65

mg/mmol

3.96

1209

2021

(4200892) Spirometry reversibility

1143

1320

7.42

307.65

2.0

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

648

217

23.73

307.65

1.3

1.1

13.68

4.02

u/ml

2.23

136

(3037692) Legionella sp identified in Specimen by Organism specific culture

330

44.23

307.65

2.0

1.1

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2693

7983

3.64

307.65

2.9

1.8

77.72

78.53

nmol/l

0.68

2505

7062

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1982

1869

11.00

307.65

1.4

1.1

62.71

17.70

iu/ml

14.75

685

565

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

580

210

21.66

307.65

2.4

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1820

3690

4.67

307.65

3.7

1.8

765.66

391.80

mg/l

1.50

1212

1898

(3009261) Glucose [Presence] in Urine by Test strip

2996

10276

3.25

307.65

4.9

2.6

0.00

estimate

-0.00

805

1749

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1619

1747

8.78

307.65

2.6

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2665

5281

5.85

307.65

4.1

2.4

1550.54

1234.82

ng/l

2.48

2397

4539

(3009508) Creatinine [Moles/volume] in Urine

1867

4054

4.37

307.65

3.6

1.8

7.18

8.16

mmol/l

14.60

1563

3435

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

653

282

18.39

307.65

1.8

1.2

1.19

1.18

g/l

0.41

632

259

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

422

199

16.14

307.65

1.4

1.1

60.18

21.63

u/ml

2.01

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

595

168

27.89

307.65

1.3

1.1

19.43

1.27

u/ml

—

(3025159) Blasts/100 leukocytes in Blood

1086

1236

7.45

307.65

6.0

3.5

0.13

0.94

1.44

400

402

(3021440) Promyelocytes/100 leukocytes in Blood

1118

1303

7.32

307.65

6.1

3.5

0.08

0.09

0.19

435

457

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1276

2548

4.28

307.65

2.9

2.0

30.01

30.39

1.15

1250

2479

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1808

3570

4.79

307.65

2.5

1.5

1.45

1.68

mg/l

1.09

1497

2749

(3022948) Iron [Moles/volume] in Serum or Plasma

1383

2679

4.51

307.65

2.9

1.9

11.86

13.78

umol/l

14.01

1302

2499

(3020630) Protein [Mass/volume] in Serum or Plasma

866

1221

5.74

307.65

2.3

3.1

66.12

65.56

g/l

0.89

814

1111

(3009343) pH of Capillary blood

830

762

8.86

307.65

6.1

3.9

7.43

7.42

1.06

151

(3007164) IgA [Mass/volume] in Serum or Plasma

1565

3218

4.37

307.65

2.0

1.4

2.75

2.41

g/l

5.86

1155

1853

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1042

483

18.48

307.65

1.9

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

4146

9057

9.31

307.65

13.8

5.1

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3599

10149

5.13

307.65

11.0

5.4

1.21

mmol/l

2.10

3037

8520

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

427

180

18.08

307.65

2.7

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1775

4213

3.88

307.65

2.5

1.9

3.22

2.96

mg/l

3.11

1556

3502

(46235355) HIV 1 and 2 tests - Meaningful Use set

1285

2529

4.36

307.65

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

560

153

28.64

307.65

1.5

1.1

—

(3000494) Fungus identified in Specimen by Culture

1433

2256

5.68

307.65

2.3

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3776

14728

3.43

307.65

6.3

3.2

799.82

654.80

e6/l

0.10

211

(3026493) Urate [Moles/volume] in Serum or Plasma

1915

4487

4.05

307.65

4.9

2.2

2383.26

7128.08

umol/l

5.19

1706

3983

(3013707) Erythrocyte sedimentation rate by Westergren method

4548

15106

6.69

307.65

9.7

2.4

17.67

11.76

mm/h

85.08

4443

13442

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

597

230

20.42

307.65

1.8

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

580

292

15.55

307.65

2.5

1.5

—

(3006315) Basophils [#/volume] in Blood

4267

9800

9.38

307.65

12.1

4.5

0.04

e9/l

10.22

3917

8146

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

802

589

11.06

307.65

1.9

2.2

38.73

41.07

u/l

1.47

737

532

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

340

168

15.18

306.63

2.1

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

334

159

15.74

306.46

2.1

1.9

—

(1616796) Gas panel - Central venous blood

417

302

10.47

305.10

5.4

3.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

279

24.68

304.97

2.1

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

308

123

18.69

304.57

2.1

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

280

24.19

304.12

2.1

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1160

2470

3.92

303.76

4.8

5.0

262.24

262.43

u/l

0.01

1104

2360

(3026008) Bacteria identified in Urine by Culture

1906

5637

3.10

301.70

3.6

2.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

684

934

5.76

301.18

2.0

1.5

—

(3015736) pH of Urine

2359

7884

2.91

301.02

4.1

2.4

5.82

5.88

0.30

772

(3002032) Base excess in Venous blood by calculation

876

1505

4.69

300.83

5.1

2.9

2.22

1.88

mmol/l

1.39

751

1252

(3014576) Chloride [Moles/volume] in Serum or Plasma

1171

2531

3.87

300.14

12.3

6.9

103.91

104.85

mmol/l

7.17

1171

2531

(3021447) Carbon dioxide [Partial pressure] in Venous blood

878

1515

4.67

299.94

5.1

2.9

5.89

5.78

kpa

1.64

842

1466

(3012544) pH of Venous blood

899

1589

4.57

298.40

5.1

3.1

7.40

7.38

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1514

3923

3.36

296.80

5.1

2.9

399.33

942.63

ng/l

5.33

1323

3150

(3017143) Hepatitis C virus Ab [Presence] in Serum

950

1766

4.37

296.41

1.6

1.5

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1278

2969

3.64

295.31

1.9

1.6

1158.02

1125.08

nmol/l

0.52

956

2139

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1999

6151

3.01

294.29

3.0

2.4

58.35

75.02

u/l

1.06

1864

5664

(3023520) Reticulocytes [#/volume] in Blood

851

1465

4.66

291.10

3.4

2.7

73.52

65.51

e9/l

5.19

610

1093

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

410

320

9.70

285.52

4.8

3.9

58.74

57.50

0.59

410

320

(40767503) Oxygen content in Capillary blood by calculation

404

310

9.86

284.51

3.5

1.9

15.71

16.26

0.93

226

123

(3021960) Folate [Moles/volume] in Serum or Plasma

1503

4016

3.24

278.52

1.7

1.4

18.95

20.38

nmol/l

2.98

1333

3350

(3021788) Differential panel - Synovial fluid

216

48.13

277.39

1.7

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

259

21.78

271.76

1.5

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4892

25113

3.74

269.21

33.4

9.3

24.48

29.33

mg/l

19.87

4572

17764

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

215

40.52

267.26

1.3

1.1

—

(3021901) Oxygen saturation in Capillary blood

346

232

11.18

264.93

4.5

2.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

717

1171

4.82

259.44

1.4

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

731

1219

4.72

258.19

12.8

6.4

25.13

24.76

mmol/l

1.43

725

1209

(3014111) Lactate [Moles/volume] in Serum or Plasma

861

1660

4.15

254.42

11.8

6.9

1.44

1.25

mmol/l

4.14

832

1606

(3000475) Leukocytes [#/volume] in Synovial fluid

227

25.32

250.50

1.8

1.2

13068.25

29723.00

e6/l

0.44

173

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

988

2152

3.72

247.08

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

386

345

8.43

243.86

5.8

3.9

7.75

8.27

kpa

4.64

376

333

(3000991) Gas panel - Venous blood

833

1631

4.07

240.56

13.3

7.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1306

3481

3.15

239.00

1.8

1.4

29468135.19

31500620.90

pmol/l

0.04

1052

2873

(3033658) Prothrombin time (PT) actual/Normal

1821

5871

2.76

237.45

6.5

3.6

86.75

90.08

5.84

1785

5762

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

589

871

5.23

237.15

1.7

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

908

1919

3.80

236.26

2.1

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

215

24.30

234.30

1.9

1.1

19.36

—

iu/ml

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

430

467

6.97

232.51

7.3

4.6

25.06

24.78

mmol/l

0.78

403

428

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

201

29.47

231.86

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

201

29.47

231.86

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

201

29.47

231.86

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

201

29.47

231.86

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

201

29.47

231.86

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

201

29.47

231.86

1.3

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

1656

5226

2.76

222.67

5.4

2.7

0.00

estimate

0.80

778

1618

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

363

338

8.05

222.12

1.4

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

682

1221

4.36

219.89

3.9

2.5

4.61

4.66

kpa

0.18

651

1172

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

259

149

12.85

215.80

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

259

149

12.85

215.80

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

259

149

12.85

215.80

1.6

1.7

—

(3011412) CD3 cells [#/volume] in Blood

259

150

12.76

215.03

2.3

1.04

1.16

e9/l

0.77

238

136

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

430

510

6.38

214.83

1.7

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1279

3564

2.99

214.72

3.9

2.5

0.88

1.20

e6/l

2.20

736

1851

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

395

426

6.98

214.59

3.4

2.1

377.44

448.66

ug/l

0.26

374

407

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

360

348

7.75

213.88

1.3

39.16

12.12

u/ml

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

158

67.65

213.51

3.7

1.5

42.90

41.52

ug/l

0.08

158

(3011397) Hemoglobin [Presence] in Urine by Test strip

1456

4392

2.81

211.64

4.3

2.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

778

1587

3.86

211.35

5.1

3.3

1.22

1.23

mmol/l

3.56

718

1337

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

875

1944

3.58

210.62

4.7

2.7

—

(3010421) pH of Blood

388

423

6.90

208.76

7.0

3.0

7.43

7.42

0.25

365

392

(3034860) Kappa light chains.free [Mass/volume] in Serum

375

396

7.11

207.28

2.6

4.2

59.30

51.21

mg/l

0.48

267

334

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

373

394

7.10

206.11

2.6

4.2

44.34

39.04

mg/l

0.38

264

332

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2127

7849

2.47

205.51

5.2

2.6

—

(3027315) Oxygen [Partial pressure] in Blood

361

370

7.31

204.51

7.1

3.1

8.32

8.65

kpa

2.05

356

361

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3655

17204

2.41

204.13

4.2

3.1

14.95

14.71

pmol/l

6.20

3319

15314

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

149

72.19

202.95

3.1

1.3

—

(3013290) Carbon dioxide [Partial pressure] in Blood

358

368

7.28

202.30

7.1

3.1

5.04

4.91

kpa

1.58

353

359

(3012501) Base excess in Blood by calculation

358

368

7.28

202.30

7.1

3.1

2.80

2.68

mmol/l

0.26

284

242

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1247

3537

2.92

201.64

4.2

2.5

1.57

2.24

e6/l

2.41

704

1827

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

362

381

7.12

200.56

2.6

4.2

3.82

1.94

ratio

0.48

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

211

16.29

197.86

4.1

3.6

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

176

26.75

197.72

2.1

1.4

68226.00

3925.00

u/ml

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

401

482

6.26

197.63

2.3

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

401

482

6.26

197.63

2.3

2.2

7.77

7.05

g/l

8.65

376

431

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

400

481

6.26

197.05

2.3

2.2

3.86

3.72

g/l

0.53

374

429

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

328

314

7.79

196.16

1.4

1.3

132.12

113.71

u/ml

0.44

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

384

460

6.27

189.72

2.3

2.2

3.13

2.97

g/l

1.79

359

408

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

603

1104

4.21

188.01

16.0

9.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2495

10192

2.31

187.87

3.4

2.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

484

737

4.99

187.66

2.1

1.6

1.62

1.50

g/l

1.31

412

619

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

516

833

4.72

187.31

5.1

3.2

24.37

24.19

mmol/l

0.51

507

816

(3044889) 12 lead EKG panel

3742

18174

2.34

186.73

5.7

3.0

—

(3044941) Cell count panel - Synovial fluid

157

32.63

186.06

1.7

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

380

462

6.17

185.12

2.3

2.2

10.63

10.54

g/l

0.09

353

405

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

141

53.85

184.49

1.7

1.1

57.41

62.96

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

216

199.09

183.87

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

216

199.09

183.87

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

216

199.09

183.87

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

216

199.09

183.87

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

438

625

5.29

182.01

3.3

2.1

3.84

3.52

g/l

3.05

428

599

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

254

193

9.71

179.19

1.9

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

878

2162

3.22

178.75

2.3

0.21

g/l

0.24

826

2045

(40768797) Stomach Pathology biopsy report

977

2583

3.03

176.62

1.3

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

202

106

13.95

176.23

1.4

1.1

—

(3036489) Thrombin time

431

631

5.15

174.14

3.4

1.8

21.68

22.07

0.40

395

563

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

353

424

6.22

173.76

2.3

2.4

0.78

1.63

g/l

1.69

318

359

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1273

3922

2.67

173.76

2.9

3.9

2.47

2.46

mmol/l

4.70

1138

3437

(3020891) Body temperature

417

597

5.26

172.52

5.8

3.9

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

559

1031

4.15

172.19

4.4

3.1

100.42

81.33

ng/l

3.04

492

878

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

252

201

9.24

172.03

1.3

1.2

4.49

2.00

u/ml

0.58

100

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

451

698

4.88

171.40

6.5

5.0

1.77

1.67

1.08

425

648

(3041096) Erythrocytes [Presence] in Urine by Automated

1617

5641

2.44

170.54

4.9

2.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4285

22501

2.42

170.25

5.2

3.4

2.05

2.57

mu/l

1.74

3921

19996

(3037756) Immunofixation for Serum or Plasma

285

278

7.59

167.68

1.5

1.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

425

637

5.02

167.28

4.1

2.7

0.33

u/ml

0.08

259

337

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

200

115

12.72

166.42

2.3

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

317

355

6.64

166.14

1.5

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

326

378

6.42

165.64

2.3

2.2

0.07

0.06

g/l

0.03

307

340

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

316

355

6.61

165.15

1.5

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

236

184

9.43

163.56

1.3

1.2

3.38

3.95

u/ml

0.27

141

(40760888) Immunoglobulin light chains.free panel - Serum

287

296

7.18

161.33

2.5

4.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4402

23686

2.41

158.82

6.8

3.2

41.23

36.81

mmol/mol

111.88

4087

21258

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

324

392

6.14

158.23

2.3

2.2

36.14

37.89

g/l

3.60

299

340

(3042733) HLA Ab [Presence] in Serum

132

32.96

156.87

4.1

4.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

306

352

6.45

156.50

2.4

2.2

0.00

g/l

-0.00

287

315

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

304

348

6.48

156.15

2.4

2.3

0.00

g/l

-0.00

287

315

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1180

3674

2.61

156.00

1.3

1.2

1.26

2.81

u/ml

3.84

288

909

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

405

631

4.82

152.43

3.5

1.9

90.24

85.78

2.81

394

607

(40761536) Microorganisms panel - Urine sediment

727

1749

3.23

152.32

5.4

2.9

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

126

35.06

151.94

2.1

1.0

6.19

5.39

u/l

0.47

116

(3007930) Methemoglobin/Hemoglobin.total in Blood

420

686

4.60

149.66

6.9

5.0

0.86

0.89

0.80

394

635

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

307

383

5.94

145.51

1.4

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

373

565

4.93

144.76

3.7

2.0

208.17

194.94

1.60

360

537

(3004119) Hemoglobin [Mass/volume] in Venous blood

499

960

3.94

144.75

5.0

2.9

125.80

128.50

g/l

1.42

480

940

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

229

204

8.24

144.31

1.2

1.1

119.67

113.16

1.62

218

179

(3002385) Erythrocyte distribution width [Ratio]

4308

23405

2.26

141.98

36.2

11.8

15.18

14.73

6.49

4282

22737

(3001964) Herpes simplex virus Ag [Presence] in Specimen

135

21.26

141.05

2.9

1.3

—

(3013512) EKG study

1673

6367

2.22

140.03

4.9

3.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

177

112

11.52

139.57

1.5

1.2

1.92

2.90

u/ml

0.34

120

(3019550) Sodium [Moles/volume] in Serum or Plasma

4891

28198

2.65

138.72

34.0

10.6

139.11

139.88

mmol/l

73.67

4839

27032

(3027273) Bicarbonate [Moles/volume] in Venous blood

410

702

4.38

137.87

4.7

2.6

25.65

25.17

mmol/l

1.37

384

681

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

277

335

6.10

135.11

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4893

28340

2.61

134.23

34.3

10.8

4.00

3.96

mmol/l

25.83

4835

27105

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

110

36.07

133.51

1.8

1.1

37.18

21.61

1.38

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

264

307

6.34

133.50

1.2

344.82

265.41

u/ml

1.98

173

207

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

149

14.61

133.36

1.5

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3200

15761

2.00

132.32

4.5

2.4

65.95

47.17

u/l

11.74

2991

14508

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

175

119

10.71

132.22

2.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

606

1425

3.25

130.82

2.6

2.0

11.81

11.70

ug/l

0.03

529

1267

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

164

103

11.58

129.84

2.2

2.5

475.82

515.22

e6/l

0.33

136

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

221

216

7.50

129.58

1.2

1.1

—

(3044640) Blood type and Crossmatch panel - Blood

1744

6936

2.13

128.85

3.2

2.2

—

(3017569) Oxygen content in Arterial blood

134

16.73

127.58

2.1

1.8

—

(40757373) Influenza virus identified in Isolate

113

26.31

126.50

2.8

1.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

187

151

9.03

126.36

1.2

1.1

96.02

95.93

0.01

181

140

(3026250) Tacrolimus [Mass/volume] in Blood

118

22.43

125.64

40.9

26.8

8.03

7.44

ug/l

1.05

106

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

198

178

8.12

123.82

1.4

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

317

478

4.91

123.38

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

871

2600

2.62

122.76

3.2

2.8

9.37

12.04

umol/l

1.77

759

2333

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

171

127

9.80

122.20

1.3

1.1

121.25

62.00

titre

—

(3047181) Lactate [Moles/volume] in Blood

339

547

4.60

122.13

8.7

5.9

1.39

1.32

mmol/l

0.52

308

480

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

171

128

9.72

121.58

1.3

1.1

130.29

245.00

titre

0.51

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

154

11.41

120.98

2.3

2.7

0.21

0.25

e9/l

0.72

136

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2918

14212

1.93

120.02

3.0

2.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

160

112

10.38

118.71

1.7

1.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

178

147

8.82

118.38

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

159

112

10.31

117.50

1.7

1.8

—

(3024471) HLA-A [Type]

123

15.32

112.72

1.0

—

(3024932) HLA-DR beta [Type]

121

15.61

111.83

1.0

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

171

145

8.58

111.58

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

140

11.65

111.46

1.7

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

140

11.65

111.46

1.7

2.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

141

11.35

110.54

2.4

1.9

128.07

85.03

ug/min

0.42

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

118

16.07

110.51

2.2

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

139

11.57

110.21

1.7

2.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

367

691

3.95

108.91

3.9

2.4

0.67

0.66

0.15

367

686

(21494814) CD8 cells/100 lymphocytes in Specimen

122

14.45

108.78

2.2

1.6

—

(3028433) Virus identified in Specimen by Culture

122

14.45

108.78

1.2

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

380

747

3.79

106.35

2.7

1.7

—

(40761511) CBC panel - Blood by Automated count

4783

28371

2.23

101.82

26.1

8.6

—

(3019977) pH of Arterial blood

126

11.52

99.78

2.5

1.7

7.43

7.42

0.62

(3004809) Band form neutrophils/100 leukocytes in Blood

232

320

5.31

99.18

4.1

3.7

1.47

1.99

1.04

222

276

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

181

193

6.82

98.64

2.2

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1344

5279

2.05

98.33

3.1

2.2

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

35.89

96.97

1.3

42.05

89.90

mg/l

—

(3039000) Anion gap in Blood

259

406

4.68

96.25

8.6

6.9

11.44

10.97

mmol/l

1.22

237

359

(3018572) Chloride [Moles/volume] in Blood

259

406

4.68

96.25

8.6

6.9

104.00

105.14

mmol/l

2.84

237

359

(3052851) Hemolysis interference index of Serum or Plasma

309

560

4.07

96.24

4.1

2.9

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

175

189

6.73

94.32

1.1

1.2

—

(3019150) Specific gravity of Urine by Refractometry

1104

4083

2.13

94.09

5.1

2.7

1.02

kg/l

0.09

193

620

(3017732) Neutrophils [#/volume] in Blood

495

1265

2.94

91.95

3.4

2.8

5.09

4.20

e9/l

1.53

411

1026

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4907

29760

2.23

91.01

35.1

11.3

85.42

77.09

umol/l

33.89

4907

29734

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

256

418

4.49

90.67

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

252

410

4.51

89.63

1.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

197

256

5.61

89.43

1.1

1.55

1.49

g/l

0.95

173

240

(3025941) Bacteria identified in Stool by Culture

395

902

3.26

88.35

1.4

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

18.72

85.88

1.6

2.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4899

29864

2.18

85.80

21.0

7.4

25.56

25.72

u/l

0.23

4840

28422

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

329

679

3.58

85.69

2.3

1.6

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

259

451

4.21

84.77

1.4

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

254

436

4.27

84.63

1.5

1.4

288.72

262.57

ug/g

0.41

152

262

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

123

9.06

83.80

1.1

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

654

2033

2.44

82.89

2.5

2.4

188.17

149.56

ug/g

1.37

546

1609

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4427

26137

1.90

82.65

28.1

9.6

75.66

79.71

ml/min/173m2

29.88

4016

20432

(3034426) Prothrombin time (PT)

16.02

81.49

1.1

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

539

1540

2.63

81.13

3.5

2.5

58.21

66.35

ml/min/173m2

4.61

257

513

(3007566) Smooth muscle Ab [Titer] in Serum

265

488

3.98

80.70

1.3

116.88

182.05

titre

0.48

(3034770) Mitochondria Ab [Titer] in Serum

261

478

4.00

80.05

1.2

1.3

1203.57

726.11

titre

0.66

(3010144) Erythrocytes [#/volume] in Synovial fluid

18.51

79.57

1.6

1.0

113475.33

61726.73

e6/l

0.31

(3023183) Ammonium ion [Moles/volume] in Plasma

210

326

4.70

78.83

2.9

2.3

32.92

39.92

umol/l

2.06

200

297

(3009871) Measles virus Ab [Titer] in Serum

11.75

78.62

1.4

1.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

16.10

77.92

1.1

1.2

68.39

50.13

iu/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

133

130

7.39

77.86

9.1

3.4

7.37

6.24

mmol/l

3.10

117

112

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

650

2072

2.38

77.77

2.8

2.3

35.57

40.09

u/l

1.11

584

1823

(3000012) Reticulocyte production index

181

252

5.22

76.54

2.8

2.3

—

(3011436) Histone Ab [Units/volume] in Serum

28.22

76.53

1.0

—

u/ml

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

10.32

73.58

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

101

9.82

72.74

1.9

2.0

1.09

0.79

nmol/l

1.85

(3010838) Calcium [Moles/time] in 24 hour Urine

183

272

4.89

72.12

1.9

4.51

5.73

mmol/24h

3.89

166

235

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

158

205

5.58

71.80

8.1

6.0

12.04

11.32

mg/l

1.08

142

192

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

246

468

3.84

71.68

1.3

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

145

173

6.06

71.44

1.3

2.5

—

831.11

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

121

118

7.40

70.96

2.4

2.7

39.17

34.55

1.10

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

252

499

3.69

69.47

3.5

2.9

1.75

1.29

mg/l

12.02

234

460

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

173

253

4.96

69.40

1.2

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4434

26673

1.81

69.36

5.3

3.4

6.03

5.60

mmol/l

77.58

4013

24063

(3042111) Morphology [Interpretation] in Bone marrow Narrative

211

366

4.20

69.32

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

249

490

3.72

69.24

1.3

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

129

140

6.65

69.20

1.2

1.3

753.99

446.92

mg/l

0.80

118

130

(40768804) Tissue Pathology biopsy report

2225

11173

1.67

69.00

2.4

2.1

—

(3044927) Protein electrophoresis panel - Urine

103

8.52

67.35

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

116

7.21

66.66

1.2

1.5

—

(3004775) Volume in Urine collected for unspecified duration

14.33

65.91

2.2

1.8

609.92

678.40

0.42

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

172

268

4.65

64.26

3.2

2.3

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

28.59

64.17

1.2

1.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

333

840

2.92

62.78

2.8

3.0

4.22

4.42

pmol/l

2.25

286

743

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

115

124

6.68

62.05

1.1

1.3

3.80

3.50

mmol/l

1.95

105

114

(3029075) Extractable nuclear Ab panel - Serum

14.53

61.88

1.1

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

156

236

4.78

60.27

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

8.60

59.99

1.1

1.05

ratio

0.03

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

650

2309

2.12

59.34

1.7

1.5

1.64

1.36

12.19

549

2042

(3026389) Candida sp identified in Specimen by Organism specific culture

132

174

5.47

59.05

1.5

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

143

204

5.06

58.93

4.9

3.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

9.08

58.89

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

254

567

3.27

58.59

1.9

1.8

—

(4035726) Immunohistochemistry procedure

781

2989

1.99

58.31

1.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

112

128

6.30

57.41

1.2

1.4

33.40

10.00

e6/l

0.67

100

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

112

128

6.30

57.41

1.2

1.5

592.07

470.77

e6/l

0.09

104

(3047007) Chlamydophila sp Ab [Presence] in Serum

149

226

4.77

57.40

1.3

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

166

277

4.34

57.19

2.9

0.86

0.79

nmol/l

0.73

120

206

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1404

6509

1.70

56.28

1.8

1.5

1.44

1.25

mmol/l

13.88

1146

5446

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

174

307

4.11

55.93

1.2

—

(3016750) Collection duration of Urine

13.65

54.84

2.1

1.9

480.33

474.82

min

0.10

(40768443) Skin Pathology biopsy report

348

969

2.64

54.56

1.2

—

(3024928) Oxygen saturation in Venous blood

192

375

3.72

53.91

4.2

3.0

—

(3004451) EKG impression Narrative

8.99

53.79

1.4

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

11.69

53.75

2.3

3.8

—

(36660697) Celiac disease serology panel - Serum

428

1336

2.37

52.92

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

360

1036

2.56

52.85

2.5

2.3

—

(40761535) Cells panel - Urine sediment

432

1357

2.36

52.67

4.7

2.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

120

164

5.27

51.75

1.3

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

310

837

2.72

51.53

1.3

45.53

45.35

au/ml

0.00

(3022145) Colonoscopy Study observation

687

2625

1.97

51.11

1.4

1.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

4967

31703

1.87

51.06

45.2

13.5

39.59

41.15

5.73

4617

29359

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

9.14

50.98

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

172

326

3.82

50.33

1.5

1.4

—

(3045142) Bone marrow Pathology biopsy report

155

274

4.09

49.71

1.5

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

332

946

2.58

49.68

2.4

2.3

29.77

25.24

au/ml

0.16

108

(3019225) pH of Specimen

562

2020

2.08

49.35

5.5

3.3

—

(3007461) Platelets [#/volume] in Blood

4966

31767

1.85

49.27

44.3

13.4

249.38

247.06

e9/l

1.45

4896

30212

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

8.39

48.70

1.1

—

(3035941) MCH [Entitic mass]

4967

31802

1.84

48.62

44.0

13.3

30.48

30.36

4.11

4933

30965

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2029

10601

1.55

48.61

4.7

5.1

3.03

3.95

ug/l

0.65

1772

9633

(3010813) Leukocytes [#/volume] in Blood

4967

31811

1.84

48.40

44.2

13.4

7.69

6.42

e9/l

131.46

4886

30113

(3024731) MCV [Entitic volume]

4967

31816

1.84

48.28

44.1

13.4

92.36

90.99

67.15

4933

30978

(3026361) Erythrocytes [#/volume] in Blood

4967

31820

1.84

48.18

44.2

13.4

4.38

4.54

e12/l

81.14

4882

30144

(3000963) Hemoglobin [Mass/volume] in Blood

4967

31834

1.84

47.84

44.5

13.5

131.98

137.17

g/l

98.37

4932

30999

(4146454) Self-monitoring of blood glucose

10.81

47.57

2.5

1.5

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

111

157

5.08

46.19

1.8

1.6

4.25

3.26

mg/l

1.13

105

150

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4242

26151

1.59

46.16

4.4

3.2

1.35

1.19

mmol/l

41.73

3783

23613

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4496

28130

1.63

45.68

5.5

3.9

2.57

2.98

mmol/l

155.75

4057

25552

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

115

170

4.87

45.62

1.6

1.3

13.49

10.88

u/l

3.12

109

162

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

119

182

4.71

45.45

1.2

61.55

61.06

u/l

0.02

109

165

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

109

154

5.09

45.42

2.5

2.3

—

(40768446) Kidney Pathology biopsy report

12.61

44.34

1.4

1.8

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

27.79

44.28

1.0

5.50

—

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

11.01

44.21

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

8.56

44.16

1.3

1.5

—

(3024263) Appearance of Synovial fluid

12.80

43.84

1.6

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

132

5.27

42.05

1.7

2.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

169

359

3.40

42.05

1.5

1.3

33.06

35.31

g/l

1.24

145

323

(3016650) Hepatitis A virus Ab [Presence] in Serum

157

318

3.57

41.90

1.1

—

(3012441) Differential panel - Pleural fluid

146

283

3.72

41.46

1.5

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

129

228

4.08

41.41

1.3

1.2

477.26

653.14

u/l

0.52

119

220

(3037121) Protein [Mass/volume] in Urine

241

640

2.74

41.27

2.9

3.8

0.30

0.18

g/l

2.19

121

335

(3008898) HLA-B27 [Presence]

133

244

3.93

40.68

1.1

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

139

264

3.80

40.59

1.4

1.3

6.70

5.37

mmol/l

4.33

125

242

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4359

27338

1.55

39.93

4.9

3.5

1.42

1.54

mmol/l

51.08

3912

24899

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4389

27570

1.56

39.90

5.0

3.6

4.46

4.92

mmol/l

139.17

3963

25212

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

10.15

39.90

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

113

189

4.30

38.88

1.8

1.1

4.39

2.14

iu/l

1.68

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

6.61

38.74

1.6

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

6.68

38.03

4.3

2.8

—

(3000060) B lymphocytes [#/volume] in Blood

9.40

38.01

2.3

1.6

878.93

1331.00

e6/l

0.14

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

6.28

37.08

1.6

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

9.84

36.97

1.1

88.41

93.83

0.29

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

9.52

36.90

1.1

86.25

91.60

0.35

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

19.72

36.65

1.6

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

233

648

2.61

36.52

1.1

0.88

6.22

u/ml

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

114

202

4.06

36.51

4.4

4.0

56.36

55.31

0.18

107

161

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

147

313

3.39

36.47

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

15.00

36.43

1.2

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

15.44

35.98

1.1

1.0

285.82

219.31

mg/l

0.87

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

108

187

4.15

35.62

1.3

1.2

14.63

12.80

u/l

0.34

179

(3045414) Leukocytes [Presence] in Urine

256

757

2.46

35.41

2.3

1.6

—

(3003181) Sodium [Moles/volume] in Urine

133

273

3.51

34.85

1.5

1.3

64.69

64.08

mmol/l

0.05

118

201

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

6.82

34.32

1.0

1.1

98.72

92.52

1.07

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

13.89

34.26

1.2

1.0

52.32

29.88

mg/l

1.32

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

9.86

34.13

1.8

1.6

8.28

10.76

ug/l

1.24

(3017704) Immunofixation for Urine

7.14

33.97

1.4

1.8

—

(3016018) Differential panel - Cerebral spinal fluid

6.52

33.60

1.2

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

12.39

33.17

1.7

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

144

322

3.22

33.15

1.1

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

186

484

2.78

33.09

1.3

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

187

489

2.77

32.97

1.3

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

13.53

32.96

1.3

1.1

89.46

80.52

ng/l

0.06

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

175

444

2.85

32.59

1.2

1.3

184.46

224.14

miu/ml

0.63

211

(3045424) Erythrocytes [Presence] in Urine

130

276

3.39

32.43

1.8

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

183

484

2.73

31.60

1.3

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

244

748

2.37

31.23

1.1

339.00

238.33

titre

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

17.52

31.11

1.7

1.2

0.35

0.39

ug/l

—

(3046861) Legionella sp Ag [Presence] in Urine

34.86

30.84

1.1

1.0

—

(40768806) Pleura Pathology biopsy report

134

301

3.20

30.65

1.5

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

108

210

3.69

30.60

1.6

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

109

214

3.66

30.47

1.6

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

133

300

3.19

30.23

1.2

1.3

45.22

47.72

u/l

0.05

119

257

(3024522) Salmonella sp identified in Specimen by Organism specific culture

108

212

3.66

30.20

1.6

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

6.27

29.93

1.7

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

6.27

29.93

1.7

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

107

212

3.62

29.54

1.6

1.5

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

7.98

29.54

2.0

2.8

68.17

79.59

u/l

0.07

(3045788) Cell count panel - Pleural fluid

123

269

3.29

29.35

1.6

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

107

213

3.61

29.35

1.6

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

107

213

3.61

29.35

1.6

1.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

10.83

29.23

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

7.44

29.18

1.4

1.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

122

4.57

29.13

2.4

2.5

0.80

0.75

g/24h

0.08

(3023199) Leukocytes [#/volume] in Pleural fluid

138

327

3.04

28.95

1.6

1.4

5255.93

3580.94

e6/l

0.20

222

(3022621) pH of Urine by Test strip

350

1281

2.00

28.89

4.0

2.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

138

4.31

28.84

1.3

—

(21494755) Public health laboratory ask at order entry panel

173

2801

0.42

28.42

1.3

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

11.87

28.36

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

5.98

28.18

5.9

3.4

62.98

77.66

mg/l

0.63

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

100

4.93

28.07

1.1

1.3

89.56

87.04

u/l

0.07

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

4.99

27.60

1.1

1.3

40.15

19.41

u/l

1.29

(3051651) Icteric interference index of Serum or Plasma

147

4.09

27.41

6.3

3.5

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

7.86

26.74

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

507

2144

1.74

26.64

1.7

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

108

233

3.33

26.35

5.3

2.8

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

677

3105

1.62

26.18

1.4

1.3

—

(21494434) Karyotype in Bone marrow

196

3.55

26.08

1.4

1.2

—

(3047189) Immunofixation for 24 hour Urine

5.50

26.01

1.6

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

147

3.99

25.96

1.3

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

111

4.44

24.98

1.5

8.15

6.35

u/l

0.34

(3019832) Treponema pallidum Ab [Presence] in Serum

297

1081

2.00

24.88

1.4

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

4.92

24.43

1.6

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

4.92

24.43

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

118

4.24

23.97

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

118

4.24

23.97

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

123

305

2.90

23.94

1.5

1.4

169434.79

35100.18

e6/l

1.32

176

(3035880) pH of Pleural fluid

137

3.91

23.20

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

44.08

22.86

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

207

2902

0.49

22.83

1.9

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

12.80

22.75

1.1

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

158

459

2.48

22.75

1.1

16.92

9.90

u/ml

0.41

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

5.07

22.72

1.4

65.59

59.32

0.44

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

205

676

2.19

22.21

1.3

1.2

—

(1002224) Polysomnography panel

162

482

2.42

22.19

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

160

3.58

21.89

1.1

1.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

7.54

21.72

5.6

1.3

227.30

149.00

umol/l

0.31

(3001893) Eosinophils/100 leukocytes in Pleural fluid

5.43

21.70

1.3

1.4

1.51

3.03

0.74

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

6.19

20.50

1.4

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

8.48

20.41

1.1

1.2

80.33

61.86

—

(40768795) Lymph node Pathology biopsy report

120

323

2.67

20.16

1.4

1.2

—

(3049717) Cytology report of Urine Cyto stain

268

1015

1.91

20.04

2.9

3.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

113

3.98

20.00

1.0

286.00

290.13

mg/l

0.17

103

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1540

8686

1.35

19.95

4.2

21.46

21.15

0.31

703

4620

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

4.72

19.91

1.1

1.0

15.60

3.33

u/ml

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

120

3.87

19.88

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

120

3.87

19.88

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

8.17

19.87

1.0

1.2

90.50

71.00

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

208

3.10

19.79

2.9

1.7

21.49

33.07

mg/l

1.07

(3020491) Glucose [Moles/volume] in Blood

111

3.99

19.74

2.0

1.5

7.64

6.08

mmol/l

3.72

(3006922) Hepatitis E virus Ab [Presence] in Serum

128

3.74

19.57

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

6.04

19.54

1.1

1.3

—

(3023410) Appearance of Cerebral spinal fluid

5.00

19.54

1.3

1.8

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

6.57

19.44

1.3

1.2

30.86

23.29

0.46

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.87

19.35

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

697

3438

1.50

19.21

3.2

5.1

25.34

38.44

ug/l

0.45

576

2844

(3008295) Osmolality of Serum or Plasma

155

3.41

18.98

1.4

1.6

270.31

277.16

mosm/kgh2o

1.40

129

(44816559) Phosphatidylethanol [Mass/volume] in Blood

102

261

2.80

18.85

1.6

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

215

2.99

18.75

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

6.25

18.62

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.10

18.23

3.5

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

6.10

18.23

3.5

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.97

18.22

2.8

2.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

230

2.86

17.75

1.4

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

228

853

1.93

17.70

1.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

7.11

17.32

1.3

1.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

4.14

16.79

1.5

1.2

1.20

1.61

promille

0.93

(40761539) Cells [Type] in Urine sediment by Light microscopy

5.53

16.19

1.3

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.11

16.17

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

130

1899

0.47

16.05

1.7

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

121

3.48

15.67

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

6.27

15.60

1.4

1.5

—

(3003694) ABO and Rh group [Type] in Blood

1296

7354

1.32

15.43

1.5

1.3

—

(3014271) Vancomycin [Susceptibility]

5.12

15.42

2.9

2.5

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

116

3.50

15.31

1.5

1.4

12.25

21.04

u/ml

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

6.09

15.21

1.2

1.4

4.36

15.62

1.59

(3016038) Potassium [Moles/volume] in Urine

111

3.53

14.96

1.3

1.1

33.58

38.39

mmol/l

0.74

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

102

3.63

14.73

2.1

1.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

18.95

14.70

1.7

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

3.71

14.59

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

265

2.54

14.53

1.4

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

7.78

14.24

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

17.05

14.22

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

141

3.14

14.10

4.7

6.2

341.39

407.25

umol/l

2.48

116

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

275

1171

1.70

14.04

1.1

134.26

149.22

iu/ml

0.23

456

(3011648) Oxygen content in Venous blood

157

3.00

13.95

5.9

3.0

11.07

11.10

0.02

157

(3033705) Calcium.ionized [Moles/volume] in Venous blood

165

2.94

13.90

3.3

2.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

5.17

13.87

1.2

1.1

1.98

2.14

mmol/l

0.21

(21494567) Legionella sp IgM Ab [Presence] in Serum

15.50

13.78

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

5.13

13.32

2.6

3.9

5.46

8.54

mg/l

1.48

(3048879) Bone marrow aspiration report

5.01

13.01

2.3

2.6

—

(3000330) Specific gravity of Urine by Test strip

238

995

1.72

13.00

4.3

2.8

—

(3006576) Bicarbonate [Moles/volume] in Blood

3.83

12.85

5.4

7.8

25.02

25.39

mmol/l

0.19

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

116

3.26

12.83

1.1

8.74

11.51

iu/ml

—

(3035637) Corticotropin [Mass/volume] in Plasma

236

2.51

12.67

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

129

3.09

12.52

2.9

2.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

412

1988

1.50

12.50

2.7

1.9

12.66

13.44

nmol/l

1.17

358

1805

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

205

2.61

12.39

1.5

1.3

12.20

0.66

nmol/l

0.49

195

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

201

2.63

12.37

1.5

1.3

0.15

nmol/l

—

(3032057) Clostridioides difficile [Presence] in Stool

6.09

12.19

2.1

1.7

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

4.13

12.14

6.5

8.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

187

2.67

12.09

1.6

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

13.02

11.89

1.1

1.0

—

(3000034) Microalbumin [Mass/volume] in Urine

104

3.29

11.83

2.5

1.8

47.50

27.39

mg/l

0.38

(3014051) Protein [Presence] in Urine by Test strip

131

471

1.99

11.51

3.6

2.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

188

2.62

11.50

1.2

1.5

319.46

315.71

pmol/l

0.03

162

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

109

367

2.12

11.40

1.1

1.31

2.19

u/ml

0.46

179

(44813793) Dust mix specific IgE antibody measurement

107

3.19

11.34

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

176

705

1.79

11.17

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

4.92

11.15

2.4

2.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

5.50

11.10

1.0

1.1

—

(3011985) Renin [Units/volume] in Plasma

205

2.51

11.01

1.3

1.5

50.81

58.17

mu/l

0.15

181

(3006653) Thiamine [Moles/volume] in Blood

5.63

10.88

1.0

1.7

125.35

136.62

nmol/l

0.36

(3010726) Horse dander IgE Ab [Units/volume] in Serum

296

2.22

10.77

1.1

1.52

1.29

u/ml

0.12

147

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

112

3.05

10.56

1.9

1.7

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

3.47

10.46

2.4

2.5

41227.46

43157.50

ug/l

0.29

(4034850) Laboratory test

172

700

1.76

10.38

12.4

6.7

—

(40765096) Chromosome analysis panel by Banding

3.56

10.29

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

253

2.28

10.18

1.0

2.88

3.61

u/ml

0.21

117

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

5.39

9.98

1.5

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

5.39

9.98

1.5

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

5.39

9.98

1.5

1.0

—

(3003338) MCHC [Mass/volume]

3627

23878

1.21

9.87

39.1

12.1

329.68

332.85

g/l

75.42

3606

23639

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

178

2.52

9.83

1.5

1.2

—

nmol/l

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

10.14

9.77

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.61

9.67

1.1

1.2

136.48

381.05

ug/l

0.59

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

498

2616

1.38

9.57

9.4

4.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

4.40

9.51

1.4

1.0

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

3.80

9.46

1.4

20.45

21.54

0.06

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1119

6583

1.25

9.43

3.0

0.70

0.88

ug/l

6.64

781

4396

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

10.37

9.41

1.2

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.06

9.31

1.3

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

330

2.06

9.25

1.1

3.73

4.27

u/ml

0.13

167

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

5.14

9.11

1.1

1.0

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

243

2.23

9.09

1.0

1.57

2.33

u/ml

0.52

(3009214) Lutropin [Units/volume] in Serum or Plasma

104

382

1.94

8.71

1.4

11.51

11.89

u/l

0.09

318

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

10.97

8.69

1.3

2.1

—

(3002256) Pathology report gross observation

682

3818

1.30

8.53

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.68

8.51

6.4

6.5

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

9.13

8.42

1.7

1.6

44.00

45.07

umol/l

0.05

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

13.30

8.35

12.5

8.5

5.64

4.36

mmol/l

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

13.30

8.35

1.7

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

7.47

8.35

2.1

1.3

—

(3006270) Folate [Moles/volume] in Blood

137

2.60

8.34

1.1

322.45

374.69

nmol/l

0.87

126

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

3.93

8.32

1.0

1.2

1707.88

1378.32

miu/ml

0.53

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

5.19

8.32

1.2

1.1

355.05

0.61

mg/l

0.47

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

4.90

8.26

1.1

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

3.68

8.24

1.4

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

7.93

8.23

1.2

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.46

8.21

1.3

1.0

0.56

0.99

mmol/l

0.36

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

3.18

8.08

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

3.95

8.05

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.69

7.97

1.4

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.49

7.93

2.7

1.8

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

15.37

7.68

1.4

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

7.51

7.60

1.2

1.0

6.60

5.67

iu/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

317

1.96

7.51

1.1

0.51

1.47

u/ml

1.29

145

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

3.98

7.51

1.0

30.86

32.00

ng/l

0.04

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

8.04

7.49

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

232

2.12

7.39

1.1

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

201

935

1.54

7.33

1.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

3.89

7.29

1.0

861.14

856.57

ng/l

0.01

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.00

7.24

1.4

1.2

—

iu/ml

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.50

7.17

1.1

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

348

1.89

7.15

1.9

1.8

192.19

219.63

pmol/l

1.93

325

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.48

7.12

1.2

1.3

0.35

0.27

g/l

2.45

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

203

2.17

7.10

1.0

0.21

0.83

u/ml

0.47

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

541

3013

1.30

7.02

4.7

3.7

31.87

32.05

0.15

408

1815

(3008402) Methanol [Moles/volume] in Serum or Plasma

8.87

7.02

1.1

—

mmol/l

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

142

615

1.65

6.98

3.0

4.1

92.12

1363.92

u/ml

1.38

131

558

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.57

6.85

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

7.57

6.85

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

3.81

6.81

1.0

295.08

295.33

ng/l

0.00

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

7.10

6.60

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.60

6.47

1.1

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

5.81

6.47

1.3

1.0

418.09

35.06

u/l

0.60

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

9.22

6.27

1.7

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

173

2.18

6.17

1.8

1.7

1.76

1.78

u/field

0.01

(3010370) Gastrin [Moles/volume] in Serum or Plasma

4.12

6.16

1.2

1.4

45.72

24.07

pmol/l

0.85

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.64

6.10

4.1

4.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

108

2.50

6.00

3.2

2.3

224.53

204.05

u/l

0.83

108

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

6.65

5.99

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

8.38

5.98

1.2

0.82

1.17

ml/s/173m2

—

(3051593) INR in Capillary blood by Coagulation assay

3.55

5.94

7.3

23.9

—

(3020393) Adenovirus Ag [Presence] in Stool

5.97

5.93

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.82

5.75

1.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

3.47

5.75

1.6

1.3

16.71

14.17

pmol/l

1.02

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

7.68

5.72

1.2

1.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

4.20

5.62

1.2

16.70

17.89

u/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

6.62

5.61

1.0

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

431

0.38

5.55

1.4

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

11.82

5.48

1.5

1.2

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

11.82

5.48

1.0

2.2

—

(40768441) Liver Pathology biopsy report

194

2.02

5.31

1.5

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

124

2.29

5.29

1.7

1.6

1.78

3.18

u/field

0.75

(1761482) Bacteria [#/volume] in Urine by Culture

121

543

1.59

5.27

5.3

3.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

255

1332

1.37

5.18

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

408

1.68

5.18

1.4

1.8

319.06

304.77

mu/l

0.16

374

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

10.13

5.15

1.0

1.1

—

(3020650) Glucose [Presence] in Urine

2.94

5.13

1.8

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

7.09

5.09

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.82

4.98

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

7.80

4.96

1.2

1.0

—

(3013466) aPTT in Blood by Coagulation assay

7.80

4.96

1.0

34.45

35.47

—

(3036071) Salmonella sp Ab [Titer] in Serum

5.76

4.81

1.2

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

3.15

4.80

2.0

2.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

103

1131

0.64

4.80

1.7

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

263

1.81

4.77

1.0

1.1

13.12

4.10

u/ml

0.62

140

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.36

4.75

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.36

4.75

1.4

1.3

278.45

368.13

pmol/l

0.28

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

3.80

4.67

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.80

4.67

1.3

1.0

—

(3014891) Appearance of Pleural fluid

3.45

4.65

1.3

1.1

—

(40758292) HTLV I+II Ab panel - Serum

3.35

4.47

1.3

1.5

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

4.73

4.45

1.9

4.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

5.12

4.43

1.5

2.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

117

2.19

4.33

1.1

2.1

6.00

10.39

umol/l

1.13

(40763480) Human metapneumovirus Ag [Presence] in Specimen

7.09

4.32

1.5

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.34

4.20

1.2

1.4

112.94

102.63

nmol/24h

0.09

(3024869) Neuronal Ab [Presence] in Serum

7.97

4.19

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

7.97

4.19

1.3

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.93

4.09

5.5

7.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.45

4.09

1.0

1.2

—

(3030313) Adrenal Ab [Titer] in Serum

9.45

4.09

1.3

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.84

4.08

1.2

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

165

1.94

3.99

2.3

2.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

3.09

3.99

1.1

1.0

9.82

14.87

u/ml

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.43

3.97

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

340

1.63

3.92

1.3

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.73

3.90

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

104

2.18

3.88

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.97

3.85

1.9

4.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

320

1.65

3.84

1.9

2.2

4554.53

6287.96

u/l

0.18

130

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

6.38

3.71

7.3

4.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

9.92

3.70

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

9.92

3.70

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

7.09

3.55

2.3

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

5.80

3.50

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.64

3.45

1.7

1.8

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.69

3.38

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

4.73

3.33

1.0

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

6.30

3.33

2.3

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

339

1.57

3.31

1.2

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

2.49

3.26

2.3

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.54

3.23

1.1

1.01

71.74

u/ml

0.52

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.18

3.21

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

7.09

3.16

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

7.09

3.16

8.7

1.9

—

(3003740) Influenza virus B Ag [Presence] in Specimen

338

1.56

3.14

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

2.09

3.12

4.9

2.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

287

0.44

3.11

1.2

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

218

1209

1.29

3.07

3.0

4.0

12325.91

2182.12

u/ml

0.39

181

1051

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

3.07

3.05

1.2

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

725

0.65

3.05

1.6

1.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

176

0.36

2.98

1.1

1.4

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

5.15

2.93

1.3

1.9

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.94

2.88

1.5

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.54

2.83

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.25

2.81

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

3.27

2.81

1.7

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

155

1.79

2.81

1.3

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

7.08

2.77

1.3

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.72

2.76

1.0

1.1

—

(3019174) dRVVT (LA screen)

5.51

2.74

1.4

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.39

2.72

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

202

0.38

2.71

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

329

1.51

2.67

1.5

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.54

2.62

1.0

1.2

—

(3000285) Sodium [Moles/volume] in Blood

3.25

2.60

1.2

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

246

0.46

2.56

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.96

2.56

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

245

0.46

2.54

1.4

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.75

2.53

1.1

1.9

—

(4212803) Bone marrow aspirate examination

3.75

2.53

1.1

1.0

—

(4281824) Cell count and differential, peritoneal fluid

446

0.60

2.53

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

263

0.48

2.51

1.4

—

(3034988) Calcium [Moles/volume] in Capillary blood

3.12

2.49

1.5

1.9

1.21

1.18

mmol/l

0.54

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

243

0.46

2.49

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

243

0.46

2.49

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

7.08

2.37

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

7.08

2.37

3.2

1.2

4.46

4.70

mmol/l

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

7.08

2.37

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.31

2.35

1.2

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.31

2.35

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.31

2.35

1.0

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

124

664

1.33

2.34

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.78

2.32

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

4.13

2.24

1.0

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

4.13

2.24

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

146

1.70

2.21

1.9

1.4

93.83

90.57

umol/l

0.14

146

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.95

2.18

1.7

1.8

1.22

1.19

mmol/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

4.72

2.18

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.07

2.14

1.5

1.3

137.11

176.21

mmol/24h

1.25

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.36

2.12

1.9

2.7

1.35

1.32

ug/l

0.02

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

260

1.50

2.11

1.2

7.14

6.53

mmol/l

1.05

212

(3051387) C reactive protein [Mass/volume] in Capillary blood

104

553

1.34

2.09

6.4

2.4

26.79

29.39

mg/l

0.29

337

(3043238) Trisomy 21 risk [Likelihood] in Fetus

216

0.49

2.06

1.4

1.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

4.25

2.02

1.2

1.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.60

2.00

1.5

1.1

0.74

0.72

umol/24h

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.15

1.96

1.1

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

212

0.50

1.96

1.3

1.4

—

(3005033) Fetal Nuchal fold Thickness US

209

0.51

1.89

1.3

1.4

—

(3026480) Teichoate Ab [Titer] in Serum

3.86

1.88

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.86

1.88

10.0

7.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.86

1.87

1.9

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

170

0.46

1.86

1.5

1.7

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.43

1.80

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.54

1.75

1.0

1.1

—

(3036180) Methadone [Presence] in Urine

2.04

1.67

1.1

1.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.93

1.65

1.0

8.80

7.33

u/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

200

1189

1.20

1.65

1.7

—

(3026726) Creatinine [Moles/volume] in Specimen

2.92

1.64

1.4

1.5

503.43

1193.06

umol/l

—

(3023511) Choriogonadotropin [Units/volume] in Urine

149

1.57

1.61

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.36

1.58

1.7

1.8

0.40

0.47

u/field

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

3.54

1.52

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.93

1.47

1.5

1.8

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

2.36

1.43

1.2

1.7

77.56

68.26

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

2.36

1.43

1.2

1.7

452.11

498.22

mu/l

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.43

1.43

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

226

1378

1.17

1.43

1.7

1.8

—

(1761868) Lipid panel - Serum or Plasma

1353

10094

0.93

1.42

3.2

2.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

3.22

1.41

1.4

2.9

—

(40768800) Prostate Pathology biopsy report

122

1052

0.82

1.39

1.1

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.66

1.33

2.0

1.1

1.74

1.49

umol/24h

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.13

1.29

1.3

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.67

1.27

1.2

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

217

0.62

1.27

1.1

1.4

1.67

1.58

g/l

0.54

217

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

2.50

1.25

1.0

7.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

122

717

1.21

1.4

34.31

38.11

iu/l

0.52

611

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

550

0.77

1.20

1.5

—

(3002619) Bacteria identified in Specimen by Culture

2.08

1.20

1.4

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

375

1.29

1.18

2.0

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

497

3828

0.91

1.18

1.4

—

(3015183) Erythrocyte sedimentation rate

1.60

1.16

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

111

936

0.84

1.07

1.4

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

678

0.81

1.03

2.0

1.7

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

1.93

1.02

1.7

1.5

31.67

53.15

pmol/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

223

1.34

0.98

1.5

1.6

—

(3032868) Hemoglobin electrophoresis panel in Blood

2.36

0.96

1.3

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.24

0.93

4.0

10.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

133

1079

0.87

0.84

2.1

1.5

23.18

2.52

mg/l

6.65

116

697

(1617658) Protocol used for examination of sentinel lymph nodes

298

0.76

0.79

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.91

0.75

1.6

1.4

193.71

97.50

ng/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

147

1.35

0.75

1.3

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

231

1.26

0.68

1.8

1.4

0.16

0.31

nmol/l

3.20

169

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.86

0.68

1.4

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.65

0.67

13.4

3.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

521

0.84

0.65

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.77

0.64

2.6

2.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

114

716

1.13

0.60

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

198

1.25

0.59

3.1

6.5

143.11

65.49

u/ml

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.42

0.55

1.2

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

185

1426

0.92

0.55

3.2

4.8

42.01

67.98

u/ml

1.55

180

1397

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.38

0.52

1.9

2.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

208

0.78

0.51

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

126

1.29

0.51

1.0

1.1

0.79

3.44

u/ml

0.80

(3011288) Drugs identified in Urine by Screen method

291

1.17

0.44

7.7

1.9

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.42

0.0

1.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.54

0.42

3.6

2.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.48

0.40

1.2

1.8

—

(3016879) Cocaine [Presence] in Urine

489

1.12

0.39

1.9

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

107

1.26

0.37

1.1

1.0

1.09

0.62

u/ml

—

(3033799) Differential panel - Peritoneal fluid

1.29

0.36

2.4

1.6

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.27

0.30

1.0

1.4

0.05

1.50

u/ml

—

(3027008) Opiates [Presence] in Urine

541

1.09

0.28

1.8

1.5

—

(3028300) Cannabinoids [Presence] in Urine

542

1.09

0.28

1.8

1.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

140

1.16

0.24

20.8

16.2

1367.43

1413.80

nmol/l

0.12

127

(3025130) Human papilloma virus identified in Specimen

321

0.90

0.22

1.8

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

217

0.88

0.22

1.4

1.2

142.03

189.21

pmol/l

1.53

217

(3014599) Egg white IgE Ab [Units/volume] in Serum

121

1.17

0.22

1.0

1.2

0.65

3.55

u/ml

1.85

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.22

0.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

0.22

0.0

1.3

—

219.13

—

(3027944) Amphetamines [Presence] in Urine

536

1.06

0.16

1.8

1.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.13

0.16

3.9

8.1

39.75

40.30

u/l

—

(3000764) Benzodiazepines [Presence] in Urine

538

1.05

0.15

1.9

1.5

—

(3044007) Cell count panel - Peritoneal fluid

1.15

0.13

1.9

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

154

1.10

0.13

3.5

7.7

—

(40768793) Breast Pathology biopsy report

108

738

1.04

0.11

1.4

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

204

1.08

0.11

1.2

1.4

35.81

37.72

u/l

0.11

179

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

136

1.09

0.10

16.1

10.9

795.90

899.33

nmol/l

0.45

127

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.04

0.09

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.10

0.08

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.88

0.06

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

252

1800

0.99

0.04

1.4

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

235

0.99

0.00

1.8

1.5

0.98

0.97

g/l

0.05

235

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.98

0.00

2.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3008607) Semen analysis panel

0.00

-0.00

0.0

1.4

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

-0.00

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

1.00

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.92

-0.00

2.8

2.2

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: IBD_PULM – Respiratory diseases principally affecting the interstitium, IBD co-morbidites

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Respiratory diseases principally affecting the interstitium, IBD co-morbidites (IBD_PULM)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints